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SUMMARY 
Testicular cancer (TC) is the most frequently diagnosed cancer in male adults between 
ages 20 and 40 years and its incidence has dramatically increased over the last 40 
years. There are considerable geographic, ethnic and temporal variations in the global 
incidence of TC. The histological spectrum of TC and the typical incidence peak at 
very young age suggest that risk factors for the TC operate early in life, possibly 
already in utero. Therefore, we assumed that exposure to herpesvirus infections 
(Epstein-Barr virus, EBV, and cytomegalovirus, CMV), maternal smoking or to a 
specific pattern of steroid hormones (high oestrogens and low androgens) in utero 
might contribute to TC development. To ensure the quality and validity of studies 
investigating the role of endogenous hormones as measured in biological samples 
stored for many years (up to 22 years) at 20OC, validation studies investigating the effect 
of storage time should precede the analyses of precious case-control samples. 
 
A case-control study was nested within three Nordic maternity cohorts from Finland, 
Sweden and Iceland. All three participating cohorts collected serum samples from 
pregnant women during the first or early second trimester. Over-generation linkages 
of the maternity cohorts’ data with that from nation-wide population census and 
cancer registries enabled identification of women with offspring diagnosed with 
histologically verified TC. Eligible TC cases whose mothers had donated a serum 
sample to one of the maternity cohorts were selected for the study. Control mothers 
had a male offspring free of TC at the time when the TC case was diagnosed and were 
matched to the index mothers by date of birth of the son. To assess the effect of 
storage time on hormonal measurements, a validation study was conducted using samples 
selected randomly from those donated every other year since the launching of the 
Finnish Maternity Cohort. Cotinine levels, Immunoglobulin (Ig)M and IgG antibodies 
to EBV and CMV and hormones levels were measured in serum samples of index and 
control mothers by the respective laboratory assays. 
  
Deterioration of the serum samples with long-term storage can result in attenuation of 
the biomarker-disease risk estimates and/or misclassification of exposure among the 
cases and the controls. Although our results from the validation study did not show a 
consistent pattern of hormone level variation with storage time, matching for calendar 
time at blood donation is needed to control for the effect of storage time on measured 
hormone levels.  
 
We conducted the first study on a possible association of congenital infection with 
EBV and CMV and risk of TC in the offspring. We found elevated EBV IgG antibody 
levels more frequently in the mothers of nonseminoma TC cases than in the control 
mothers. However, further studies are needed to rule out the possibility that EBV 
reactivation is a marker of a pathogenetic process rather than the causal factor. 
Decreased risk of TC diagnosed during the prepubertal period in the offspring of 
CMV IgG seropositive mothers was revealed but lack of specific IgM antibodies ruled 
out the possibility of congenital infection in CMV seronegatives. 
 
Maternal smoking during pregnancy does not appear to be associated with risk of TC 
as shown by our direct approach of measuring maternal serum cotinine levels and the 
meta-analyses of studies with questionnaire data on maternal smoking. Therefore, 
most probably maternal smoking is not a risk factor for TC. However, further research 
is needed, especially to understand the role of alcohol.  
 
We provide the first direct evidence that the interplay of maternal steroid hormones 
(DHEAS, androstenedione, and oestradiol) in early pregnancy is important in the 
aetiology of TC. Offspring of mothers with the highest DHEAS levels had a 
decreased risk of TC. Conversely, offspring of mothers with the highest 
androstenedione levels had an increased risk of TC. High maternal total oestradiol 
level showed a notably high point estimate for the increased risk of TC. The precise 
mechanisms underlying these associations remain, however, to be elucidated in future 
studies. A better knowledge of the impact of populations’ lifestyles and environments 
on endogenous hormone metabolism during pregnancy and its role in the development 
of TC would shed further light on our understanding of the aetiology of this disease. 
  
CONTENTS 
 
ABBREVIATIONS…………………………..………………………………….…... 9 
LIST OF ORIGINAL PUBLICATIONS………………………………..…………. 11 
1. INTRODUCTION…………………………………….…………………..………. 12 
2. REVIEW OF THE LITERATURE…………………………………………..….. 13 
2.1. Longitudinal approach to epidemiological studies using Nordic 
population-based registries and biobanks…………………………………...…... 
 
13 
2.1.1. Population-based cancer registration..……………..……………….……. 13 
2.1.2. Population-based biobanks…………………………...……………….…. 14 
2.1.3. Over-generation linkage………………………….…..……...…………… 15 
2.1.4. Case-control study nested with population-based registries and biobanks 16 
 2.1.5. Quality assurance of biobank-based studies……………………..………. 17 
2.2. Descriptive epidemiology of TC…………………………...…..……….…….. 19 
2.3. Histological occurrence of TC and its subtypes…………………………….. 22 
2.3.1. Seminomatous testicular tumours………………………….………….…. 22 
Seminoma……………………………………………………….….…. 23 
Spermatocytic seminoma…………………………………………..….. 23 
2.3.2. Nonseminomatous testicular tumours……………………….……….…... 23 
Embryonal carcinoma………………………………………….……... 23 
Yolk sac tumour……………………………………………...…….….. 24 
Choriocarcinoma………………………………………….……….…. 24 
Teratoma………………………………………………….…………... 24 
Mixed germ cell tumours………………………………...……….…... 25 
2.4. Natural history of TC………………………………...……..………………... 27 
2.5. Aetiology of TC……………………………………………….……………….. 29 
2.5.1. Cryptorchidism and other disorders of testicular differentiation …...…… 29 
2.5.2. Carcinoma in situ (CIS)...................................…………………...….….. 30 
2.5.3. Inherited susceptibility………………………………………...……….… 30 
2.5.4. Ethnic and migration factors……………………………………………... 32 
2.5.5. Prenatal and perinatal exposures..........………………………..…………. 33 
Prenatal exposure……………………….…………….……………… 33 
Maternal hormone exposure……………………………..……....…… 35 
 Maternal infection exposure…………….………………..…………... 37 
Maternal exposure to smoking and alcohol consumption……..…...… 38 
Maternal exposure to endocrine disrupting chemicals…..............…… 39 
2.5.6. Postnatal exposure…………………………………………………….….. 40 
Personal risk factors…………………………………..……………… 40 
Lifestyle factors………………………………………..……………… 42 
Occupational exposure……………………………….………………. 44 
3. AIMS OF THE STUDY..…………………………………………………….…... 47 
4. MATERIALS AND METHODS……………………………...…………...…….. 48 
4.1. Serum banks ……………..…………………………………………………… 48 
4.2. Cancer registries………..……..…………………………..………………….. 49 
4.3. Study population ……………..…………………………...………………….. 50 
4.4. Laboratory methods……………..……………………...……………………. 53 
4.5. Statistical methods……………………………………………………………. 55 
5. RESULTS ………………….………………………………….……………..…… 57 
Study I: Stored FMC serum samples can be used to study hormone-disease 
associations………………………………………………………………………… 
 
57 
Study II: Increased risk of TC in the offspring of mothers with high antibody 
levels to EBV – but no consistent association with antibodies to CMV………..….. 
 
57 
Study III: No excess risk of TC in the offspring of mothers smoking during 
pregnancy……………………………………………………..……………………. 
 
58 
Study IV: The interplay of maternal steroid hormones in early pregnancy is 
important in the aetiology of TC in the offspring………………………….……….. 
 
61 
6. DISCUSSION…………………………………………………………………..…. 63 
6.1. Strengths and limitations of the study………………………………………. 63 
6.1.1. Biobank-based approach in the context of TC aetiology……...………… 63 
6.1.2. Representativeness of the study population…………………….….……. 65 
6.1.3. Validity of the assays and analyte measurements………………………. 67 
6.2. Comparison of the study results with findings from other studies……….. 68 
6.2.1. Association of maternal infections and risk of TC in the offspring…….. 69 
6.2.2. Association of maternal smoking and risk of TC in the offspring……… 70 
6.2.3. Association of maternal steroid hormones and risk of TC in the 
offspring…………………………………………………………….………….. 
 
71 
  
7. CONCLUSIONS……………………………………………………………..…… 74 
8. ACKNOWLEDGEMENTS……………………………………………….…..….. 76 
9. REFERENCES………………………………………………………………...….. 78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maternal risk factors and testicular cancer in the offspring: A nested case-control study 
THL — Research 9
ABBREVIATIONS 
 
AFP alpha-fetoprotein 
ASR age-standardised incidence rate 
BLT bench-lag time 
BMI body mass index 
CCS case-control study 
CI confidence interval 
CIS carcinoma in situ 
CMV cytomegalovirus 
CV coefficient of variation 
DES diethylstilbestrol  
DHEAS dehydroepiandrosterone sulphate 
DMF dimethylformamide 
DNA deoxyribonucleic acid 
EBV Epstein-Barr virus 
EBNA Epstein-Barr virus-related nuclear antigen 
EIA enzyme immunoassay 
ELISA enzyme-linked immunosorbent assay 
FMC Finnish Maternity Cohort 
GD gestational day 
hCG human chorionic gonadotropin 
HLA human leukocyte antigen   
IARC International Agency for Research on Cancer 
ICD-O/3 International Classification of Diseases for Oncology, 3rd Edition  
IEMA immunoenzymetric assay 
IGF-1 insulin-like growth factor-1  
IGFBP-1 insulin-like growth factor binding protein-1 
IGFBP-3 insulin-like growth factor binding protein-3 
IgG immunoglobulin G 
IgM immunoglobulin M 
IRMA immunoradiometric assay 
LMP latent membrane protein  
Katsiaryna Holl 
 
THL — Research 10
LOQ limit of quantitation 
MIS Müllerian Inhibiting Substance 
NCCS nested case-control study 
np non-phosphorylated 
OR odds ratio 
PAF population-attributable fraction 
PID personal identifier 
pGH placental growth hormone 
RNA ribonucleic acid 
SES socioeconomic status 
SHBG sex hormone binding globulin 
SNP single-nucleotide polymorphism 
TC testicular cancer 
TGS testicular dysgenesis syndrome  
TNM Classification of Malignant Tumours, T – tumour, N – lymph nodes, M – 
metastasis 
VCA viral capsid antigen 
  
Maternal risk factors and testicular cancer in the offspring: A nested case-control study 
THL — Research 11
 
LIST OF ORIGINAL PUBLICATIONS 
 
This thesis is based on the following original articles referred to in the text by their 
Roman numerals: 
 
I. Holl K, Lundin E, Kaasila M, Grankvist K, Afanasyeva Y, Hallmans G, 
Lehtinen M, Pukkala E, Surcel HM, Toniolo P, Zeleniuch-Jacquotte A, Koskela 
P and Lukanova A (2008): Effect of long-term storage on hormone 
measurements in samples from pregnant women: the experience of the Finnish 
Maternity Cohort. Acta Oncol 47:406-412. 
 
II. Holl K, Surcel HM, Koskela P, Dillner J, Hallmans G, Wadell G, Kaasila M, 
Olafsdottir GH, Ögmundsdottir HM, Pukkala E, Stattin P and Lehtinen M (2008): 
Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular 
cancer in the offspring: a nested case-control study. APMIS 116:816-822. 
 
III. Tuomisto J, Holl K, Rantakokko P, Koskela P, Hallmans G, Wadell G, Stattin 
P, Dillner J, Ögmundsdottir HM, Vartiainen T, Lehtinen M and Pukkala E 
(2009): Maternal smoking during pregnancy and testicular cancer in the 
offspring: a nested case-control study. Eur J Cancer (in press). 
 
IV. Holl K, Lundin E, Surcel HM, Grankvist K, Koskela P, Dillner J, Hallmans G, 
Wadell G, Ögmundsdottir HM, Pukkala E, Lehtinen M, Stattin P and Lukanova 
A (2009): Endogenous steroid hormone levels in early pregnancy and risk of 
testicular cancer in the offspring: A nested case-control study in the Nordic 
countries. Int J Cancer (in press). 
 
 
These articles are reproduced with the kind permission of their copyright holders. 
Katsiaryna Holl 
 
THL — Research 12
1. INTRODUCTION 
 
Testicular cancer (TC) is undoubtedly a unique and complex multifactorial disease. Its 
incidence is increasing markedly worldwide, albeit with geographic and ethnic 
differences, making it an important source of morbidity for young males. The 
increasing incidence of TC parallels the great changes in lifestyle and environment 
around the world. This suggests that TC may be added to the list of so-called 
“civilization diseases”. 
 
Among the particular biological features of TC is the wide heterogeneity of its various 
histological types, mimicking virtually any tissue type in the body, including 
caricatural reflection of early embryo in a teratoma. TC is believed to be result of 
disturbances in both gonadal development and germ cell differentiation. Therefore, 
foetal development in utero is a critical period when maternal risk factors can 
contribute to the transformation of the germ cells into (pre)-carcinoma in situ (CIS) 
cells. Remarkably little, however, is known about the risk factors which might 
contribute to the development of TC. 
 
The attempt to identify the risk factors of TC in the present study stems from the 
unique opportunities of over-generation linkage and direct exposure assessment in 
prospectively collected maternal samples.  
Maternal risk factors and testicular cancer in the offspring: A nested case-control study 
THL — Research 13
2. REVIEW OF THE LITERATURE 
 
2.1. Longitudinal approach to epidemiological studies using 
Nordic population-based registries and biobanks 
 
For the identification of risk factors and causality inference as well as for the 
determination of population-attributable fraction (PAF) beyond increases/decreases in 
cancer incidence, longitudinal studies nested in cohorts of stored biological samples are 
especially suitable. In the Nordic countries, there exists a series of established biobanks 
with decades of follow-up, and comprehensive, population-based health registries 
linkable by unique personal identifiers (PID). This setting enables studies with adequate 
statistical power even for rare diseases and exposures (Pukkala et al. 2007). 
 
2.1.1. Population-based cancer registration 
 
The nationwide Nordic cancer registries have been in operation since the 1950s and 
have virtually complete country-wide coverage of cancer occurrence. Approximately 
950,000 cancer cases diagnosed from 1953 to 2004, 1.6 million cases diagnosed from 
1958 to 2004, and 37,000 cancer cases diagnosed from 1955 to 2005 are registered 
respectively in the Finnish Cancer Registry, the Swedish Cancer Registry, and the 
Icelandic Cancer Registry. Close to 80,000 new cancer cases are registered annually 
in these 3 countries: approximately 26,000 in Finland, 51,000 in Sweden, and 1270 in 
Iceland. The Finnish Cancer Registry since 2007, the Swedish Cancer Registry since 
2005, and the Icelandic Cancer Registry since 2003 have followed the International 
Classification of Diseases for Oncology, third edition (ICD-O/3) for coding the 
primary site of cancer. 
 
Notification of all diagnosed (mostly >95%) histologically confirmed cancer cases 
must be sent by physicians, hospitals or laboratories to the cancer registry either in 
paper or electronic format. Information received is immediately stored in the 
electronic database of the registry. Visual and automatic checking procedures for any 
erroneous code combinations or illogical order of dates both at data entry and coding 
are applied. If information on a cancer case is incomplete or controversial, requests 
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for further information are sent to the physicians, hospitals or laboratories (Teppo et 
al. 1994). Furthermore, cancer registry files are regularly linked with population-
based registers where the correctness of PID is checked, and the complete name, vital 
status, possible date of emigration as well as the official place of residence at the time 
of diagnosis are obtained. Cancer registry files are also annually linked to the causes 
of death registries (Bray and Parkin 2008, Parkin and Bray 2009). 
 
For each case reported to the cancer registry, information on name, PID, residence, 
primary site and date of diagnosis, basis of diagnosis, stage, malignancy, histology, 
treatment and follow-up time is stored. In addition, information about the identity of 
the notifying hospitals or laboratories, histological specimen numbers, tumour grade, 
TNM Classification of Malignant Tumours (TNM), site of metastases, characteristics 
of the treatment, or reason for not being treated are available and can be utilized for 
various purposes. Each cancer considered to be an independent new primary entity is 
registered and coded separately. 
 
The national cancer registries are highly regarded both by the scientific and health 
care communities in the Nordic countries. Furthermore, the output of the registries is 
widely used in research, administration, or health education on all levels. 
 
2.1.2. Population-based biobanks 
 
Biobanks may be defined as “a system, which will store one or many types of 
biological specimens for later analysis from single or multiple studies under 
conditions which permit efficient retrieval and optimum stability of the samples” 
(Winn et al. 1990). Biobanks have a fundamental role in epidemiological studies 
because they function as the repository of biological materials from which molecular-
based exposure assessment can be made.  
 
There are 17 biobanks in the Nordic countries (Finland, Sweden, Norway, and 
Iceland, Figure 2.1). Since 1966 altogether two million donors have donated more 
than four million biological samples, stored at –10 oC to –135 oC (Pukkala et al. 
2007). In the past ten years, informed consent has been collected from all persons 
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donating biological samples, clearly indicating to the donors that the material will be 
used for research purposes. For older samples either pertinent legislation or opting-out 
announcement have formalized their use for research purposes. In addition to stored 
biological samples, data on date of sample collection, PID, demographic, reproductive 
or medical history, and lifestyle factors may be available in the biobanks’ data files. 
 
 
Figure 2.1. Map of the Nordic countries indicating the coverage areas of the serum banks 
(with permission of Pukkala et al. 2007). 
 
All Nordic biobanks are independent entities that make their own decisions, but since 
1994 have committed to a wide range of collaborative initiatives. To facilitate joint 
studies similar policies for quality assurance, logistics, study designs as well as for 
terms of collaboration have been adopted. Furthermore, research projects using these 
biobanks need appropriate permission from the boards of the biobanks.  
 
2.1.3. Over-generation linkage 
 
Every resident of the Nordic countries has a unique PID that is used in all official 
registries in these countries. The Nordic health data infrastructure and PID are utilised 
to allow electronic linkages to obtain data on numerous registry-based health 
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indicators. Over-generation linkage of the cancer registry, population census registry, 
and the biobank data enable identification of parents with offspring who have been 
diagnosed with malignant disease. Additionally, hospital discharge registries, 
perinatal outcome registries, cause of death registries, registries of infectious diseases 
and other disease specific registries can be used for over-generation linkage due to the 
availability of PID.  
 
Permission for linkage information between the biobanks, population-census registries 
and cancer registries can be obtained from the national data protection authorities, 
national or local ethical committees. Identification and access of the individuals who 
have donated samples to the Nordic biobanks is not allowed in the Nordic countries, 
but according to the informed consent the samples can be used for medical research. 
 
2.1.4. Case-control study nested with population-based registries 
and biobanks 
 
Nested case-control design is commonly used in molecular epidemiological studies 
within a cohort. This approach is particularly useful when complex and expensive 
measurements are conducted. In essence, initially blood samples for all members of 
the cohort are collected at the time of entry and frozen. The cohort is defined and 
followed up until a sufficient number of diseased individuals (cases) are identified. 
Exposure assessment and other pertinent information is thereafter obtained from 
biobank and registry files, but only for cases and a sub-sample of disease-free 
individuals (controls), but not for all members of the cohort (Santos Silva 1999, 
pp.182–183). 
 
In a nested case-control design, for each cancer case of interest, typically one to four 
matching controls of the same gender are randomly selected following the incidence 
density sampling principle from the population-based registry (Doll and Peto 1981). 
However, controls have to be alive at the time of case’s diagnosis, to be free of the 
disease of interest and to be at risk of being cases at the time of the case’s diagnosis, 
to have donated a sample and to be born around the same time as the case. The 
relative risk estimated as the odds ratio (OR) will then be based on the incidence rate 
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ratio in the source population between those exposed and not exposed. This holds true 
regardless of a disease rarity assumption, provided that the control sampling is 
independent of the exposure assessment given the matching criteria (Kass and Gold 
2005, pp. 327–329).  
 
The goal of matching is to balance the ratio of cases to controls within matched sets, 
and to make distributions of the potentially confounding variables among controls 
more like those of cases. In case of heterogeneous biobanks, matching for sub-cohort 
is essential. A difference of one to two months in sampling date is sometimes 
necessary due to seasonal variation of the biomarkers tested in biological samples 
(Agborsangaya et al. 2009, to be published). As freezing and thawing can affect a 
number of biomarkers it is also strongly recommended to match by the number of 
freeze-thaw cycles of a given sample. Matching may increase random error, e.g., 
matching on a non-confounder or variables intermediate in the causal pathway 
between exposure and disease reduces the point estimates. 
 
There are certain practices in control selection that are bound to specific features of 
the sample materials unique for the biobanks. First, because most biobank data bases 
do not include variables indicating how many times a sample has been used as a 
control and how much serum is left, it is often necessary to pick up one or two extra 
control candidates that will be used if the actual controls are missing or do not contain 
enough material. In some studies based on biobanks persons who have been 
diagnosed with other cancers have not been accepted as controls, although formally 
they would be eligible at least until the date of cancer diagnosis of the respective case. 
However, this causes only a negligible theoretical error, because the pool of eligible 
controls for each case normally includes hundreds of subjects (Pukkala et al. 2007). 
 
2.1.5. Quality assurance of biobank-based studies 
 
A potential weakness of studies based on historical biobank samples is the stability 
and quality of the old samples. The oldest samples in the Nordic biobanks are more 
than 30 years old and many are stored at the relatively high temperature of –25C. 
Therefore, an appropriate set of validation studies for monitoring deterioration of 
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samples over time including testing for desiccation, integrity of the container, and 
stability of the analytes over long storage periods is needed. Although there is some 
scientific understanding of stability for many biochemical analytes, data is limited for 
newer molecular-level assays (Gislefoss et al. 2008). Furthermore, enzymes and 
vitamins may be less stable under storage conditions compared to antibodies, organic 
and fatty acids, carbohydrates and trace metals.  
 
A better understanding of intra- and inter-individual variability and the natural history 
of newer biomarker is needed. In addition, greater interchange between laboratory 
specialists, biobank keepers and epidemiologists is also needed. The numbers of 
freeze-thaw cycles need to be recorded. The effect of freeze-thaw cycles could in 
some cases be prevented by sufficient aliquoting or other suitable methods.  
 
The quality of the samples stored in biobanks always needs to be assured by the 
following procedures: (a) serum is obtained by a standardized procedure and all 
aliquots are prepared in the same way, (b)? samples are aliquoted into appropriate 
airtight tubes to prevent freeze-drying effect with long-term storage, (c) storage 
temperature is monitored regularly, (d) the time between sample collection and 
freezing for long-term storage is kept as short as possible, (e) laboratory assays must 
ensure high specificity and sensitivity. As a part of the quality assurance of the studies 
based on biobank material, it is recommended to conduct pilot studies to validate 
proposed analyte measurements (hormones, antibodies, trace elements) for each 
particular research purpose. 
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2.2. Descriptive epidemiology of TC 
 
The worldwide incidence of TC has dramatically increased over the last 40 years 
(Huyghe et al. 2003, Huyghe et al. 2007). This includes the Nordic countries (Figure 
2.2). Epidemiological studies suggest that the risk of TC is strongly associated with 
the year of birth and that the younger generations have an increased risk compared to 
previous ones (Bergström et al. 1996, McKierman et al. 1999, Richiardi et al. 2004). 
 
 
Figure 2.2. Age-standardised incidence rate (ASR) of TC in Nordic countries for years 1970-
2006 (Pukkala, 2007, http://astra.cancer.fi/cancermaps/Nordic). 
 
There are considerable geographic and ethnic variations in the global incidence of TC. 
The disease mainly affects Western populations, with average rates in developed areas 
of the world six times higher than those in developing areas (Bray et al. 2006a). TC 
incidence exhibits extremely low rates in black and other non-white races in 
comparison to white population (Shah et al. 2007). This can be seen in the world age-
standardised incidence rate (ASR) data from the 1998 and 2002 for most developed 
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countries (Figure 2.3). ASR of TC ranges from about 1/100,000 in Asian and 
African/African-American populations to approximately 9/100,000 in Denmark and 
Norway (Curado et al. 2007). 
Figure 2.3. Age-standardised incidence rate of TC for years 1998-2002. 
 
In most countries TC is rare, representing about 0.5-1.5% of all malignancies in the 
males. About 500,000 new cases were diagnosed worldwide in 2002 (GLOBOCAN 
2002), with the vast majority being germ cell tumours and occurring in young adult 
males. In populations considered to have a high frequency of the disease, the life time 
risk (to the age of 75 years of age) is approximately 0.5–1% (Bray et al. 2006c). Age-
specific incidence rate of TC in 1997-2006 in Finland, Sweden and Iceland shows an 
incidence peak between the ages of 20 and 40 years (Figure 2.4). While the majority 
of TC occurs between 20 and 40 years of age and accounts for 20% of all male 
cancers in these ages, the peak incidence for teratoma and embryonal carcinoma is at 
ages 20-35 years, and for seminoma is at ages 25-45 years (Figure 2.4). The 
incidences of the various types of TC decline rapidly after the peak age. 
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Figure 2.4. Age-specific incidence rate of major TC types in Finland (a), Sweden (b) and Iceland (c) for years 1997-2006. 
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2.3. Histological occurrence of TC and its subtypes 
 
In general, TC has been divided into three biologically distinct categories of 
prepubertal (infantile and childhood) TC, postpubertal (adult) TC, and spermatocytic 
seminoma. There is some evidence that the origin and biology of prepubertal and 
postpubertal TC are distinct from each other. Approximately 75% of prepubertal TCs 
are of germ cell origin, as compared to more than 90% of those TC cases found in the 
postpubertal period (Cushing et al. 2006). Non-germ cell testicular neoplasms 
comprise one third of TC cases in children and less than 10% in adults. In children, 
yolk sac tumour and teratoma are the most frequent tumours, while seminoma and 
embryonal carcinoma are rare. Testicular neoplasms in adults often consist of 
seminoma, embryonal carcinoma, or mixed testicular germ cell tumours. Furthermore, 
there is a strong association between postpubertal TC and CIS. No such association 
has been observed in any prepubertal TC (Bahrami et al. 2007). 
 
Genetic studies have shown that postpubertal TCs are often aneuploid with consistent 
chromosomal abnormality, i.e., gain of short arm of chromosome 12, usually in the 
form of an isochromosome, i(12p) (Reuter 2005). By contrast tumours arising in 
prepubertal gonads tend to be diploid with structural abnormalities of chromosomes 1, 
3, 6 and without the 12p amplification (van Echten et al. 2002). 
 
For clinical purposes TCs have traditionally been separated into seminomatous and 
nonseminomatous tumours. Seminomatous tumours grow more slowly and have 
better prognosis than nonseminomatous tumours. 
 
2.3.1. Seminomatous testicular tumours 
 
Classic seminoma and spermatocytic seminoma are the two types of seminomatous 
tumours (Table 2.1, p. 26). 
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Seminoma 
 
Seminoma is the most common testicular germ cell neoplasm, accounting for 
approximately 50% of these tumours. It is also a recognizable component in a large 
proportion of mixed germ cell tumours. In seminomas, the malignant cells have many 
similarities with primordial germ cells, and the tumour may simply reflect the malignant 
expansion of a clone of primordial germ cells (Ulbright 2004). The peak incidence is 
between 25 and 40 years of age. Before puberty, seminoma is extremely rare.  
 
Spermatocytic seminoma 
 
Spermatocytic seminoma is an uncommon germ cell neoplasm that accounts for 1% to 
2% of all testicular tumours. Classic seminoma and spermatocytic seminoma are 
believed to have a different pathogenesis and a separate cell of origin. The cellular 
origins of spermatocytic seminoma appear to be more differentiated than those of 
seminoma and capable of spermatogenesis (Stoop et al. 2001). Spermatocytic 
seminoma typically occurs in men older than 50 years of age, and has only 
occasionally been seen in younger patients (Chung et al. 2004). 
 
2.3.2. Nonseminomatous testicular tumours 
 
These types of tumours are composed of embryonal carcinoma, yolk sac tumour, 
immature or mature teratoma, choriocarcinoma, and other rare testicular tumours 
(Table 2.1, p. 26). They are often seen in various combinations, referred to as mixed 
testicular germ cell tumours, which may also include seminoma. 
 
Embryonal carcinoma 
 
Pure embryonal carcinoma, even if relatively rare, is the second most common single-
cell-type testicular germ cell tumour after seminoma. Embryonal carcinoma as a 
component, however, is present in more than 80% of mixed germ cell tumours (Cushing 
et al. 2006). Pure embryonal carcinoma occurs most frequently between 25 and 35 years 
of age, which is ten years earlier than the peak age for seminoma. Embryonal carcinoma 
is uncommon in young children and rare after the age of 50 years. 
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Yolk sac tumour 
 
Yolk sac tumour is a germ cell neoplasm that differentiates in the direction of the 
embryonic yolk sac and extraembryonic mesenchyme. It is the most common 
testicular neoplasm in the juvenile population, accounting for approximately half of 
prepubertal testicular tumours (Ross et al. 2002). In children, the median age at 
presentation is 16 month (range, newborn to 11 years). Childhood yolk sac tumour 
does not appear to be associated with cryptorchidism (Ro et al. 2000) or CIS (Bahrami 
et al. 2007). Yolk sac tumour in children is almost always seen in the pure form. By 
contrast, in adults it is seen only admixed with other neoplastic germ cell elements 
and the pure form is extremely rare. Foci of yolk sac tumours are found in 40% of 
mixed germ cell tumours in adults. 
 
Choriocarcinoma 
 
Choriocarcinoma is extremely rare and accounts for less than 1% of testicular tumours 
(Ro et al. 2000, Ulbright 2004). However, as a component, choriocarcinoma is seen in 
approximately 8% of mixed germ cell tumours. Choriocarcinoma typically occurs in 
the second or third decades of life (Bahrami et al. 2007). 
 
Teratoma 
 
Teratomas are tumours composed of variable types of tissue representing one or more 
of the germinal layers of endoderm, mesoderm, and ectoderm. A tumour composed of 
only one of the three germ cell layers is defined as monodermal teratoma. Mature 
teratomas are composed of entirely mature and well-differentiated components. By 
contrast, immature teratomas contain embryonic or foetal-like tissues, which are 
typically accompanied by mature elements (Bahrami et al. 2007). 
 
Teratoma occurs in both children and adults, but the biological behaviour of the 
tumour is substantially different between the two groups. In adults, teratoma as a pure 
neoplasm is uncommon (only 2%3% of all germ cell tumours); however, as a 
component, it is present in almost 50% of mixed germ cell tumours. By contrast, in 
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children almost all teratomas are pure neoplasms. Teratoma is the second most 
common prepubertal testicular neoplasm after yolk sac tumour, accounting for 14% of 
these tumours. Most prepubertal teratomas are exclusively composed of mature 
tissues; nevertheless, almost all of them behave in a benign manner regardless of the 
maturity of their components. On the other hand, most postpubertal teratomas are 
immature, although completely mature teratomas in adults are at risk of metastases. In 
other words, the immaturity of teratomous components is not an indicator of poor 
biological behaviour in the primary tumour; rather, the age of the patients is 
important. Most prepubertal teratomas are seen in children younger than 4 years with 
a mean age of 20 months. Postpubertal teratomas occur after the age of 15 years 
(Cushing et al. 2006). 
 
Mixed germ cell tumours 
 
Mixed germ cell tumours of the testis are the second most common testicular germ 
cell tumours in adults (following seminoma), comprising 30% to 50% of cases 
(Cushing et al. 2006). Tumours that contain seminoma occur at a later age than 
tumours without a seminomatous component. Mixed germ cell tumours are rarely 
seen in prepubertal gonads. 
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Table 2.1. Characteristics of TC histological subtypes. 
Histological type Frequency  Age at diagnosis, years 
 
 
Seminomatous testicular tumours 
 
Seminoma 
 
50% of all TC 2540  
Spermatocytic seminoma 
 
12% of all TC >50  
 
Nonseminomatous testicular tumours 
 
Embryonal carcinoma 
 
 
relatively uncommon as a pure form;  
> 80% of all mixed germ cell tumours 
2535  
Yolk sac tumour 
 
 
50% of all prepubertal TC; 
40% of all mixed germ cell tumours 
011  
Choriocarcinoma 
 
 
< 1% of all TC; 
~8% of all mixed germ cell tumours 
20–30  
Teratoma 
 
 
 
1014% of all prepubertal TC; 
23% of all postpubertal TC; 
~50% of all mixed germ cell tumours 
 
<4 and >15  
Mixed germ cell tumours 
 
3050% of all TC in adults >15  
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2.4. Natural history of TC 
 
TC has its origin in foetal life as a result of a defect in the early development of 
primordial germ cells or gonocytes into spermatogenic cells (Skakkebaek et al. 1987, 
Rajpert-De Meyts et al. 1998, Skakkebaek et al. 2001). In the human foetus, 
differentiation of gonocytes into infantile spermatogonia is a relatively long and slow 
process. If testicular differentiation is impaired, either due to an inherent genetic 
defect or an exposure to environmental factors, this process may be delayed or 
arrested. This probably happens shortly after the arrival of the migrating primordial 
germ cells in the genital ridge (Adamah et al. 2006). Hormonal imbalances in the 
cellular microenvironment may lead to errors in mitosis-meiosis switch in “sexually 
confused” germ cells and can result in polyploidization. Other errors in cell division 
and progressive genomic aberrations would lead to further genomic instability and 
formation of transformed “pre-CIS cells” (Rajpert-De Meyts 2006). These cells 
remain quiescent until they are stimulated to proliferate by gonadotropin-mediated 
signals and form germ cell tumours either in infancy or after puberty in young 
adulthood (Figure 2.5). 
 
Ninety-five percent of TC derives from germ cells that do not have gonadotropin 
receptors (Skakkebaek et al. 2003) but depend on testicular growth factors that are 
produced under gonadotropin stimulation. Gonadotropin levels are high during 
infancy, decline rapidly after 3 months of age (Andersson et al. 1998), and remain 
very low until puberty, when they rise to adult levels. The age-adjusted incidence of 
TC closely follows the changes in the gonadotropin levels, which suggests that 
tumourogenesis depends on permissive action of gonadotropins in the testis (Rajpert-
De Meyts and Skakkebaek 2000, Golub et al. 2008). 
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Figure 2.5. Scheme illustrating the current understanding of the pathogenesis of testicular 
CIS in relation to germ cell differentiation. EC, embryonal carcinoma; TER, teratoma; YST, 
yolk sac tumour; CHC, choriocarcinoma (adapted from Rajpert-De Meyts 2006, Skakkebaek 
et al. 2001). 
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2.5. Aetiology of TC 
 
Histology and the early age-specific incidence peak of TC suggest that its risk factors 
operate early in life, possibly already in utero. Increase of incidence of TC within a 
generation suggests that changes in the occurrence of exogenous aetiological factors 
may contribute to the development of TC. However, genetic predisposition probably 
sets the stage for TC (Table 2.2, p. 45). 
 
2.5.1. Cryptorchidism and other disorders of testicular 
differentiation 
 
The most established factor associated with the risk of TC is cryptorchidism. Some 
studies have reported a two to four-fold increased risk of TC and a PAF of 10% 
associated with cryptorchidism (Boyle and Zaridze 1993, Moller et al. 1996, 
Walschaerts et al. 2007, Akre et al. 2009), other studies even a five to ten-fold 
increased risk of TC associated with cryptorchidism (Moss et al. 1986, Giwercman et 
al. 1987, Swerdlow et al. 1997b, Weir et al. 2000, Dieckmann and Pichlmeier 2004, 
Akre et al. 2009). Recently several studies have reported that surgical treatment of 
cryptorchidism before puberty decreases the risk of TC from five to one or two-fold 
(Herriton et al. 2003, Pettersson et al. 2007b) whereas another study did not find such 
an association (Myrup et al. 2007). It has been hypothesized that cryptorchidism may 
be the first step in (a partially genetic determined) a causal chain of events that can 
lead to TC or a less severe stage of testicular dysgenesis syndrome (TGS) (Garner et 
al. 2005). The hypothesis proposed that abnormal testicular development, which could 
have numerous primary causes, leads secondarily to hormonal or other malfunctions 
of the Leydig and/or Sertoli cells during male sexual differentiation, leading in turn to 
increased risk of the reproductive disorders (Sharpe and Skakkebaek 2008). 
 
A significant increase in the prevalence of cryptorchidism over the last 40 years has 
been observed in Denmark (Boisen et al. 2004) but not in its neighbour, Finland 
(Toppari et al. 2001, Boisen et al. 2004). Differences in semen quality (Jørgensen, 
2002) and in prevalence of cryptorchidism (Boisen et al. 2004) at birth and at 3 
months of age as well as differences in TC incidence (Adami et al. 1994, Curado et al. 
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2007) have been noted between Denmark and Finland. This contrast could be 
reflected by environmental/lifestyle differences between the two countries and/or 
ethnic differences in susceptibility (Sharpe and Skakkebaek 2008). 
 
Other testicular abnormalities such as testicular atrophy (Dieckmann and Pichlmeier 
2004), gonadal dysgenesis (Dieckmann and Skakkebaek 1999, Dieckmann and 
Pichlmeier 2004), and subfertility/infertility (Dieckmann and Skakkebaek 1999, Fossa 
and Kravdal 2000, Jacobsen et al. 2000, Dieckmann and Pichlmeier 2004, Doria-Rose 
et al. 2005, Walsh et al. 2009) have been reported as risk factors for TC. 
 
2.5.2. Carcinoma in situ (CIS) 
 
CIS of the testis is a distinct histological pattern preceding the development of 
seminomatous and nonseminomatous germ cell tumours of the testis (Skakkebaek et 
al. 1982). The link between TC and CIS may also be related to a condition referred to 
as TGS, which occurs already in utero with varying levels of severity. TC represents 
the most severe form of the TGS, whereas CIS is a less severe form of TGS (Boisen et 
al. 2001, Sharpe and Skakkebaek 2008). 
 
Fifty percent of patients diagnosed with CIS of the testis develop invasive TC within 
5 years of diagnosis. It is thought that all patients harbouring CIS cells at puberty will 
eventually develop TC (Jørgensen et al. 1990). It is now generally agreed that nearly 
all TC cases including seminoma or nonseminoma are preceded by the presence of 
CIS cells, with the exception of two rare tumour types: infantile germ cell tumours 
and spermatocytic seminoma (Reuter 2005, Bahrami et al. 2007). There is a higher 
probability of developing nonseminomatous lesions if the transition from CIS to 
invasive cancer occurs at a young age (Rorth et al. 2000). By contrast, seminomatous 
lesions are more likely to result from the progression of CIS at older ages. 
 
2.5.3. Inherited susceptibility 
 
Familial clustering of the TC with affected first degree relatives occurs in 1 to 2.8% of 
all TC cases (Sonneveld et al. 1999, Dieckmann and Pichlmeier 2004). Case reports 
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of familial TC support family history as a possible TC risk factor independent of 
cryptorchidism (Fuller and Plenk  1986, Yoshimura et al. 1993, Han and Perschel 
2000, Gupta et al. 2005). Genetic anticipation may also be responsible for many 
father-son TCs (Han and Perschel 2000). Inherited susceptibility is especially strong 
in bilateral TC (Heimdal et al. 1996a). 
 
Familial studies have shown that brothers of TC patients have an eight to ten-fold 
increased risk of TC. Among fathers and sons the point estimates were considerably 
lower, approximately four-fold (Heimdal et al. 1996a, Heimdal et al. 1996b, 
Hemminki and Li 2004). A significantly higher risk of TC in dizygotic twins has been 
observed compared to monozygotic twins (Swerdlow et al. 1997a), suggesting that an 
environmental component may also act in utero to cause TC. A possible genetic effect 
in the twin studies can be found only in a case of assessment of TC risk in the twin 
brothers of affected patients. However, the numbers have been too small in most 
studies for any conclusions to be drawn (Braun et al. 1995, Swerdlow et al. 1997a). 
 
Positive associations between TC and leukaemia, distal colon cancer, kidney cancer, 
melanoma, connective tissue tumours, prostate cancer, lung cancer, breast cancer, and 
non-Hodgkin’s or Hodgkin’s lymphoma in the family have been reported (Dong et al. 
2001, Spermon et al. 2001, Hemminki and Li 2004, Hemminki and Chen 2006, 
Walschaerts et al. 2007). 
 
A segregation analysis suggested a recessive mode of inheritance, with penetrance 
among homozygotes of about 45%. However, it has been conceded that there may be 
more than one predisposition gene involved in TC and that the mode of inheritance is 
probably more complex (Nicholson and Harland 1995, Heimdal et al. 1996b). 
 
A linkage study based on families with at least two affected cases of TC did not yield 
clear evidence for linkage of any autosomal gene (Rapley et al. 2000, Rapley et al. 
2002, Crockford et al. 2006), indicating that, like many other cancers and chronic 
diseases, there are several moderate-risk genes involved. However, X-chromosome 
linkage (i.e. no male-to-male transmission) provided the first statistically significant 
evidence for a TC predisposition locus. The gene called TGCT1 is located at Xq27 
and seems to be associated with the risk of bilateral TC and perhaps cryptorchidism 
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(Rapley et al. 2000, Rapley et al. 2003). However, the set of pedigrees in these studies 
was quite small. 
 
Genetic association studies have been mostly focused on the role of human leukocyte 
antigen (HLA) genes (Lutke Holzik et al. 2004). However, the results have been 
inconsistent. For instance, one study found evidence of an association between HLA 
Bw41 and seminoma (Dieckmann et al. 1993). Two other studies also reported HLA-
associations, but not with the same loci (Kratzik et al. 1991, Özdemir et al. 1997). 
Conversely, no HLA class II associations were found in another study (Sonneveld et 
al. 2002). Genes involved in modulating the action of steroid hormones have been 
considered without conclusive evidence in some of the studies (Rajpert-De Meyts et 
al. 2002, Giwercman et al. 2004, Starr et al. 2005, Figueroa et al. 2008). One study 
showed that genetic variation in insulin-like growth factor (IGF) loci is not associated 
with risk of TC (Chia et al. 2008). Moreover, another study revealed little evidence of 
an association between 8q24 single-nucleotide polymorphisms (SNP) and risk of TC, 
especially nonseminoma (Cook et al. 2008a). 
 
Microdeletions in the Y chromosome associated with decreased fertility have been 
investigated with regard to risk of TC. However, most of the studies have yielded 
negative results (Frydelund-Larsen et al. 2003, Lutke Holzik et al. 2005, Bor et al. 
2006). An increased risk of TC was associated with some deletions in Y chromosome, 
which were associated with subfertility but could, however, be transmitted from father 
to son (Repping et al. 2003, Nathanson et al. 2005). 
 
2.5.4. Ethnic and migration factors 
 
The effects of genetic susceptibility and environmental exposure on the risk of TC 
development have also been distinguished in migration studies (Parkin and Khlat 
1996). TC continues to rise in most populations but with remarkable ethnic 
differences, indicating the influence of genetic background (McGlynn et al. 2005a, 
Jack et al. 2007, Shah et al. 2007). For instance, Finland is a relatively low TC 
incidence country, Sweden is a middle-incidence and Denmark a high-incidence 
country (Richiardi et al. 2004). Men migrating from one country to another tended to 
Maternal risk factors and testicular cancer in the offspring: A nested case-control study 
THL — Research 33
retain their country of origin risk of TC, whereas their children tended to approach the 
risk of the new home country (Hemminki and Li 2002, Ekbom et al. 2003, 
Montgomery et al. 2005) or had an intermediate TC risk between those observed in 
the first generation of immigrants and in the population to which they migrated 
(Parkin and Iscovich 1997). 
 
2.5.5. Prenatal and perinatal exposures 
 
Prenatal exposure 
 
Nausea. There are conflicting findings on whether excessive nausea during pregnancy 
is a risk factor for TC. Some studies have found excessive nausea to be associated 
with two to four-fold increased risk of TC (Depue et al. 1983, Petridou et al. 1997, 
Sonke et al. 2007), a decreased risk of TC (Moller and Skakkebaek 1997, Coupland et 
al. 2004), or no risk of TC (Brown et al. 1986, Weir et al. 2000, Cook et al. 2008b). 
As excessive nausea during early pregnancy may indicate a rapid rise in endogenous 
hormone levels such as human chorionic gonadotropin (hCG) and oestrogens 
(Furneaux et al. 2001) it is plausible that hormone levels in early pregnancy are 
involved in the mechanism ultimately leading to TC in early adulthood. However, the 
overall effect may be modest and difficult to establish in epidemiological studies 
(Sonke et al. 2007). 
 
Birth weight. Low birth weight has been investigated mainly as an indicator of foetal 
growth retardation. Some studies have found low birth weight to be associated with 
two-fold increased risk of TC (Akre et al. 1996, Moller and Skakkebaek 1997, 
English et al. 2003, Coupland et al. 2004, Cook et al. 2008b, Dusek et al. 2008). Other 
studies have found high birth weight to be associated with one and half-fold increased 
risk of TC (Akre et al. 1996, Richiardi et al. 2002, Richiardi et al. 2003), or no risk of 
TC (Sabroe and Olsen 1998, Wanderås et al. 1998, Weir et al. 2000, Rasmussen et al. 
2003). Due to the inconsistency of these results meta-analyses were conducted on 
birth weight and risk of TC (Michos et al. 2007, Richiardi et al. 2007). These 
ultimately revealed an increased risk of TC, but both for children with low birth 
weight (<2500-3000g) and high birth weight (>4000g) supporting a proposed U-
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shaped relation between birth weight and TC (Michos et al. 2007). The length of the 
child at birth was found to be a non-significant risk factor for TC (Moller and 
Skakkebaek 1997, Sabroe and Olsen 1998, English et al. 2003, Cook et al. 2008b).  
 
Timing of delivery. The relation between preterm birth and risk of TC may involve 
elevated exposure to oestrogens in utero (Weir et al. 2000). An almost 50% increased 
risk of TC was observed in males born at least two weeks early, whereas those born 
late were at reduced risk (Weir et al. 2000, Richiardi et al. 2002, Coupland et al. 
2004). There was, however, no association between preterm birth and risk of TC in 
other studies (Wanderås et al. 1998, Sonke et al. 2007, Cook et al. 2008b). 
 
Parity. Several studies (Prener et al. 1992, Moller and Skakkebaek 1997, Sabroe and 
Olsen 1998, Westergaard et al. 1998, Cook et al. 2008b) but not all (Wanderås et al. 
1998, Weir et al. 2000, Coupland et al. 2004, Sonke et al. 2007) have indicated that 
children of mothers with high parity have decreased risk of TC when compared to 
children of nulliparous mothers. It has previously been suggested that maternal 
endogenous oestrogen levels are higher in first pregnancies than in subsequent 
pregnancies (Arslan et al. 2006). More recently, a significant trend for decreased risk of 
TC both with increasing birth order and sib-ship size in male offspring was shown 
(Richiardi et al. 2004). However, neither elevated maternal hormone levels nor parental 
subfertility in the TC cases alone can explain the results (Richiardi et al. 2004). 
 
Twin pregnancies. The significant from one and half to two-fold increased risk of TC 
in dizygotic than in monozygotic twins supports a prenatal aetiology with raised 
maternal oestrogen levels during the pregnancy (Braun et al. 1995, Swerdlow et al. 
1997a). Prenatal oestrogen levels may be higher in males with a female co-twin than 
in males with a male co-twin. However, the finding of elevated risk of TC in 
male/female twins was restricted to instances where the male twin was born after his 
female twin (Swerdlow et al. 1996). 
 
Maternal age. There is contradictory evidence on whether maternal age is a risk factor 
for TC. Some studies have found older maternal age to be associated with a one and 
half or two-fold increased risk of TC (Moller and Skakkebaek 1997, Sabroe and Olsen 
1998, Wanderås et al. 1998, English et al. 2003), a decreased risk of TC (Coupland et 
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al. 2004, Cook et al. 2008b, Dusek et al. 2008), or no risk of TC (Weir et al. 2000, 
Richiardi et al. 2002, Sonke et al. 2007). The effect of maternal age on the risk of TC 
remains unclear, although it is possible that an impact of maternal age may be 
presented only in women with no prior children (Wanderås et al. 1998). 
 
Retained placenta. Retained placenta, presence of Rh-antibodies and foetal 
presentation has been associated with the risk of TC, although, other than a 
dysfunctional in utero environment, the reason for this is unclear (Moller and 
Skakkebaek 1997, Wanderås et al. 1998). 
 
Maternal hormone exposure 
 
According to the leading hypothesis on TC aetiology, exposure to a specific pattern of 
steroid hormones in utero, in particular to high levels of oestrogens and low levels of 
androgens, is the major determinant of TC risk in the offspring (Henderson et al. 
1979, Henderson et al. 1988a, Henderson et al. 1988b, Sharpe and Skakkebaek 1993, 
Sharpe 2003). 
 
High levels of oestrogens during embryogenesis may cause developmental arrest of 
foetal germ cells, which remains dormant until puberty. At puberty proliferation to 
testicular CIS and ultimately to invasive cancer (Rajpert-De Meyts and Skakkebaek 
1993, Dieckmann and Skakkebaek 1999) may then be stimulated by gonadotropins 
from the pituitary (Henderson et al. 1988a). Oestrogens also inhibit the secretion of 
Müllerian Inhibiting Substance (MIS) by the Sertoli cells, which is responsible for the 
regression of the Müllerian duct and the first phase of testicular descent. MIS also 
exerts tumour-suppressing activities. Therefore, MIS production or action in the 
critical early foetal period may lead to the appearance of abnormal gonocytes or CIS 
cells (Rajpert-De Meyts and Skakkebaek 1993, Sharpe and Skakkebaek 1993). 
 
Exposure of pregnant mice in utero to oestrogens has been found to increase the 
frequency of TGS (Yasuda et al. 1985), cryptorchidism (Walker et al. 1990), 
hypospadias (Kim et al. 2004), and TC (Newbold et al. 1987); and there is also 
evidence of impaired Leydig cell development and reduced Sertoli cell numbers, 
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resulting in impaired spermatogenesis (Yasuda et al. 1985). The same associations 
have been suggested to take place in humans (Buetow 1995, Toppari et al. 1996), 
although they are still under debate (Sharpe 2003, Sharpe and Skakkebaek 2008).  
 
Maternal exposure to pharmacological oestrogens e.g. diethylstilbestrol (DES) etc. 
during pregnancy may lead to an increased risk of TC in the offspring. Several studies 
have found from five to eight-fold increased risk of TC in relation to hormone 
consumption during pregnancy (Henderson et al. 1979, Depue et al. 1983, Toppari et 
al. 1996, Weir et al. 2000). However, the hormones studied have been varied and in 
most studies were not specified. One study found that the relationship remained 
significant even when stratifying by histology of TC (Weir et al. 2000) whereas other 
studies found no increased risk of TC with exogenous hormone consumption during 
pregnancy (Brown et al. 1986, Moss et al. 1986). There is also insufficient evidence to 
support an increased risk of TC in men exposed to DES in utero (Leary et al. 1984, 
Jensen et al. 1995, Strohsnitter et al. 2001). 
 
The most straightforward way by which the foetus is exposed to high levels of 
oestrogens, is through increased bioavailability of maternal high oestradiol levels 
naturally occurring during pregnancy (Sharpe 2003). Although this epidemiological 
data reported so far is inconsistent, increased oestrogen levels during pregnancy are 
associated with several maternal or foetal conditions such as high maternal age, first 
birth order, excessive nausea, twin pregnancy, premature birth, low and high birth 
weight (Prener et al. 1992, Braun et al. 1995, Moller and Skakkebaek 1997, Petridou 
et al. 1997, Swerdlow et al. 1997a, Sabroe and Olsen 1998, Wanderås et al. 1998, 
Westergaard et al. 1998, Weir et al. 2000, Richiardi et al. 2002, Coupland et al. 2004, 
Michos et al. 2007, Sonke et al. 2007, Cook et al. 2008b). On the other hand, 
conditions related to decreased oestrogen levels during pregnancy such as increased 
parity, smoking, pre-eclampsia, and eclampsia appear to protect against TC (Weir et 
al. 2000, Akre et al. 1996, Cook et al. 2008b). These evidences have been largely 
interpreted within the framework of the steroid hormone imbalance hypothesis. 
Although the available evidence supports the hypothesis, it is, however, far from 
being proven (Garner et al. 2008). Furthermore, it has been proposed that indicators of 
higher levels of pregnancy oestrogens are more related to seminomas, while indicators 
of oestrogen exposures associated with intrauterine growth retardation are more 
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related to nonseminomas (Akre et al. 1996). However, these issues have not been 
supported by another study (Weir et al. 2000). 
 
The amount of androgens in circulating maternal blood is also an important factor for 
the normal development of the testis and its descent during foetal life (Henderson et 
al. 1988b). Androgens have been shown to play a decisive role of Sertoli cell 
production during foetal life (Sharpe and Skakkebaek 2008) and to increase the 
cleavage and probable activation of MIS (Rajpert-De Meyts and Skakkebaek 1993). 
This was supported by animal studies where treatment with androgens reversed 
oestrogens inhibiting testicular descent (Henderson et al. 1979) and in utero exposure 
of rats to the anti-androgen flutamide resulted in cryptorchidism (van der Schoot 
1992) or in a reduced number of Sertoli cells (Atanassova et al. 2005). Furthermore, 
germ cell cancer and CIS are frequently observed in low-androgen states of various 
reproductive abnormalities, e.g., androgen insensitivity syndrome (Muller and 
Skakkebaek 1984, Cassio et al. 1990, Hannema et al. 2006, Aguilar-Ponce et al. 
2008), mixed gonadal dysgenesis (Muller et al. 1985), Klinefelter’s syndrome 
(Rajpert-De Meyts and Skakkebaek 1993). A relative excess of maternal androgens 
during pregnancy was observed in black women when compared to Caucasian women 
(48% higher testosterone levels). This provides a possible explanation for the three-
fold lower incidence of cryptorchidism and TC in black men (Henderson et al. 
1988b). On the other hand, women in China, where the incidence of TC is low, have 
increased levels of oestradiol, unconjugated oestriol and sex hormone binding 
globulin (SHBG) during early pregnancy compared to black women (Lipworth et al. 
1999, O’Brien et al. 1997). However, one study did not support either the oestrogen or 
the androgen hypothesis. Rather, lower oestrogens in case mothers may indicate that a 
placental defect increases the risk of cryptorchidism and, possibly, TC (McGlynn et 
al. 2005b). 
 
Maternal infection exposure 
 
Exposure to Epstein-Barr virus (EBV) with known oncogenic potential (Shibata et al. 
1991, Iezzoni et al. 1995, Lehtinen et al. 2003, Rezk and Weiss 2007) may be related 
to the risk of TC (Algood et al. 1988, Heinzer et al. 1993, Shimakage et al. 1996). 
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Further support for EBV aetiology of TC comes from histopathological studies 
showing that all seminomas and embryonal carcinomas expressed EBV ribonucleic 
acid (RNA), whereas the non-malignant testes did not (Shimakage et al. 1996). The 
occurrence of TC in young patients and high levels of wild-type (not mutated) p53 
protein in testicular tumour cells (Guillou et al. 1996, Gray et al. 1998) also fit the role 
of EBV in TC pathogenesis as the former may have been inactivated by Epstein-Barr 
virus-related nuclear antigen (EBNA) 5, one of the EBV oncogenes (Rajpert-De 
Meyts et al. 1994). A putative passenger role for EBV in the virus transformed 
lymphocytes, which are not infrequently present in the stromal tissues of TC (Rajpert-
De Meyts et al. 1994), however, cannot be excluded. 
 
EBV has been considered as a possible cause of TC also by analogy with its association 
with Hodgkin’s lymphoma (Evans et al. 1980, Herbst et al. 1990, Brousset et al. 1993). 
Indeed, Hodgkin’s lymphoma shows epidemiological similarities to TC with a peak age 
in adolescents and young adults (Newell et al. 1984). The occurrence of both diseases is 
frequent in high socioeconomic class with increase in white urbanised populations and 
most notably in Europe, particularly in Denmark. Both cancers with a variety of 
histological types have a low but definite familial occurrence with lifetime risk 
determined at a young age and irrespective of geographic migration later in life.  
 
Cytomegalovirus (CMV) may also be related to the risk of TC (Mueller et al. 1988). 
However, this study suggested that risk of TC may be related to a relatively late age of 
exposure to CMV resulting in damage to the development of the testis. Confounding 
by immune status of TC cases or by other risk factors of TC was not taken into 
account for this observation. So far there is no evidence showing an association 
between maternal CMV infection and risk of TC in the offspring. 
 
Maternal exposure to smoking and alcohol consumption  
 
An association of maternal smoking with the risk of TC in the offspring has been 
suggested by two ecological studies (Clemmesen 1997, Pettersson et al. 2004) 
reporting a strong geographical and temporal correlation between female smoking 
prevalence and TC incidence in the Nordic countries. A positive association between 
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parental lung cancer and TC in the offspring has been also suggested (Heimdal et al. 
1996b, Dong et al. 2001, Kaijser et al. 2003). Besides containing numerous potent 
carcinogens, tobacco smoke has several physiological effects, such as reducing 
placental blood flow and interfering with pregnancy oestrogens (Bernstein et al. 1989, 
Petridou et al. 1990) that could disturb normal testicular cell differentiation 
(Mochizuki et al. 1984). However, a number of questionnaire-based case-control 
studies have found no association between maternal smoking and risk of TC 
(Swerdlow et al. 1987, Moller and Skakkebaek 1996, Weir et al. 2000, Coupland et al. 
2004, McGlynn et al. 2006, Pettersson et al. 2007a, Sonke et al. 2007).  
 
Smoking and alcohol consumption have been associated with alterations in 
endogenous oestrogen levels (MacMahon et al. 1982, Reichman et al. 1993, Gill 
2000). Parental drinking has been linked to the risk of other childhood cancers 
(Everson et al. 1986, Moller 1993, Ji et al. 1997, Sorahan et al. 2001) or 
cryptorchidism (Damgaard et al. 2007). One study did not, however, find any 
evidence of germ cell tumours being related to maternal exposure to alcohol 
consumption (Chen et al. 2005a).  
 
Maternal exposure to endocrine disrupting chemicals 
 
Exposure to endocrine disrupters has received considerable attention as potential risk 
factors for TC over the past few decades (Joffe 2001, Skakkebaek et al. 2007). Some 
of these exposures may lead to the mutation in germ cells (Giri 2002) or malfunctions 
of the Leydig and/or Sertoli cells during male sexual differentiation (Sharpe and 
Skakkebaek 2008). In the earlier studies, exposure was estimated based on parental 
employment in exposure-prone jobs, especially jobs involving pesticide exposure. 
However, results from these studies are inconsistent, showing either a positive 
association between parental exposure-prone jobs and risk of TC (Shu 1995), or no 
association (Rodvall et al. 2003, Chen et al. 2005b. Chen et al. 2006). In fact, 
substantial exposure to pesticides can also occur in and around the home. Increased 
breast milk or blood levels of some endocrine disrupting chemicals have been found 
in case mothers compared to the control mothers (Hardell et al. 2003, Damgaard et al. 
2006, McGlynn et al. 2008). Further, significant geographic differences were revealed 
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between Denmark and Finland in the level of certain persistent organochlorine 
compounds in human placenta and breast milk (Shen et al. 2008). 
 
2.5.6. Postnatal exposure 
 
Although several findings suggest that TC originates in utero, it cannot be ruled out 
that events later during childhood or adolescence initiate or promote the development 
of TC. However, the possible mechanisms behind these associations remain 
unexplained. 
 
Personal risk factors 
 
Age. The peak incidence of TC occurs between the ages of 20 and 40 years (Bray et 
al. 2006b, Figure 2.4) which is different from that for most other cancers with peak 
normally much later in life. The incidence of TC appears to be related to steroid 
hormone activity either in utero or during the puberty. The steeply increased 
incidence of TC observed following puberty is thought to reflect the promotion of 
cells initiated during gestation to CIS by adult steroid hormones (Moller 1993, Moller 
and Evans 2003). 
 
Race. The incidence of TC varies with race. Black and other non-white races have 
extremely low rates of TC in comparison to Caucasian populations (Curado et al. 
2007). Although the reasons for the differing rates are unknown, certain hormonally 
related racial differences have been observed. Pregnancy levels of androstenedione 
and testosterone were seen to be higher in black mothers than in white mothers (Troisi 
et al. 2003a). Higher free testosterone levels have also been seen in young black men 
compared to young white men (Ellis and Nyborg 1992, Morrison et al. 2003). 
However, the possibility that other genetic, lifestyle, or environmental influences may 
contribute to this association should not be excluded. 
 
Androgen levels. The role of androgen levels during adolescence and early adult life 
has received little attention, although acne (Depue et al. 1983) and baldness (Petridou 
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et al. 1997), which are linked to higher androgen levels, have been found to be 
inversely associated with the risk of TC. 
 
Puberty. Puberty can be considered as a critical time for TC development. It is a 
period of high replication. Spermatogonia, which remain rather inactive during 
infancy and childhood, start undergoing meiosis to form spermatocytes and sperm at 
puberty, stimulated by a surge of steroid and peptide hormones. Although age at 
puberty is difficult to measure, it would appear that late age at puberty is associated 
with a marked decrease (up to 50%) in the risk of TC (Moss et al. 1986, Moller and 
Skakkebaek 1996, Weir et al. 1998, Coupland et al. 1999). Other studies did not 
support puberty as a risk factor of TC (Swerdlow et al. 1989) based on ages at 
shaving, voice changing and nocturnal emission (McGlynn et al. 2007).  
 
Body mass index (BMI). Studies of BMI and risk of TC have yielded inconsistent 
results, with some finding an almost two-fold increased risk of TC with a low BMI 
(Petridou et al. 1997, Akre et al. 2000), a three-fold increased risk of TC with high 
BMI (Garner et al. 2003) or no risk of TC (Davies et al. 1990, Dieckmann and 
Pichlmeier 2002, Rasmussen et al. 2003, Richiardi et al. 2003, Bjorge et al. 2006, 
McGlynn et al. 2007). Studies examining weight separately from BMI found no 
association between increased body weight and risk of TC (Swerdlow et al. 1989, 
Davies et al. 1990, Dieckmann and Pichlmeier 2002). 
 
Height. Many studies have examined height as a risk factor for TC (Swerdlow et al. 
1989, Gallagher et al. 1995, Akre et al. 2000, Dieckmann and Pichlmeier 2002, 
Richiardi et al. 2003, Bjorge et al. 2006, McGlynn et al. 2007, Dieckmann et al. 2008) 
showing up to three-fold increased risk of TC among men taller than 185-195cm. 
Several potential mechanisms have been proposed to explain a positive association of 
height with the risk of TC, including childhood nutrition (Dieckmann and Pichlmeier 
2002, Dieckmann et al. 2008) increased levels of IGF (Juul et al. 1994, Khandwala et 
al. 2000) or an earlier age at puberty in those of greater height (Hagg and Taranger 
1992, Karlberg 2002). 
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Lifestyle factors 
 
So far a wide variety of lifestyle factors have been examined in the research searching for 
clues in the aetiology of TC. The results have been inconsistent, with strong associations 
found with diet but weak and varied associations for socio-demographic indicators. 
 
Socioeconomic status (SES). The majority of the studies on the effect of SES and risk 
of TC have used SES indicators based on social class or education. Some studies 
(Hayes et al. 1990, Swerdlow et al. 1991, Moller and Skakkebaek 1996), but not all 
(Van den Eeden et al. 1991, Prener et al. 1992), have found positive association 
between high social class and the risk of TC. TC seems to occur much more 
frequently in the higher social classes than in the lower, perhaps due to other factors, 
such as diet or occupation. Education has also been used as an indicator of SES. One 
study found a positive association between TC and increasing educational attainment, 
although the data were not explicitly presented (Srivastava and Kreiger 2000). A 
recent study has revealed that a wide disparity in the risk of TC between high and low 
social classes (higher incidence among men with higher SES) has diminished over 
time (Pukkala and Weiderpass 2002). 
 
Physical activity. The effect of physical activity on the risk of TC is unclear. Some 
studies have found that higher levels of physical activity have a protective effect 
(Gallagher et al. 1995, UK Testicular Cancer Study Group, 1994a; UK Testicular 
Cancer Study Group, 1994b), whereas others have found an adverse effect (Srivastava 
and Kreiger 2000) or no effect (Thune and Lund 1994). However, these studies did 
not control for dietary factors. One study showed that the analysis of the TC cases 
responses found no relationship between physical activity and risk of TC, while the 
maternal responses found an inverse association (Cook et al. 2008c). 
 
Diet. Diet has been associated with the risk of TC with inconclusive results. For 
instance, meat (Sigurdson et al. 1999, Garner et al. 2003), high fat consumption 
(Sigurdson et al. 1999), milk and cheese (Davies et al. 1996, Ganmaa et al. 2002, 
Garner et al. 2003) have been found to have a positive association with TC. There 
was, however, no association between risk of TC and dietary consumption at any age 
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between birth and 18 years of age (McGlynn et al. 2007) and between risk of TC and 
dietary intake of phytooestrogens (Walcott et al. 2002). 
 
Dietary products (i.e. milk, meet and eggs) may contain the female steroid hormones 
such as oestrogens and progesterone (Hartmann et al. 1998). It is reasonable to 
hypothesize that these hormones in dietary products may be associated with the risk of 
TC (Joffe 2001, Ganmaa et al. 2002). The strength of this association is further 
supported by the recent increasing trend in TC incidence and the increased 
consumption of dietary products in developed countries starting in the 1940s and 
1950s (Sharpe and Skakkebaek 1993). Another factor contributing to the level of 
oestrogens in dietary products may be the treatment of cattle with hormones and 
antibiotics, although the impact of this practice on carcinogenesis is unknown.  
 
Urban/rural living. There have been several conflicting studies on rural and urban 
patterns of TC suggesting either a rural preponderance of TC (Talerman et al. 1974, 
Walschaerts et al. 2007), or no rural/urban differences in the rates of TC (Schouten et 
al. 1996, Petridou et al. 1997, Sonneveld et al. 1999). 
 
Late infection exposure. The secular increase of TC in developed countries could 
reflect an increasingly larger proportion of boys who are susceptible to relatively late 
infections (i.e., at or after puberty) with common childhood viruses (Mueller et al. 
1988) having gonadotropic properties. An association of TC with higher social class 
(Hayes et al. 1990, Swerdlow et al. 1991, Moller and Skakkebaek 1996) also points to 
the possibility of late infections with common childhood viruses. At a later age these 
infections are often more severe and may include testicular inflammation. For 
example, in the case of mumps, the occurrence of orchitis increases with age of 
infection in boys (Feldman 1982, p.419-440) and there have been reports of TC 
developing following atrophy of mumps orchitis (Kaufman and Bruce 1963, Beard et 
al. 1977). The eradication of mumps from the Nordic countries in 1996 indicates that 
mumps (Peltola et al. 2000), however, can not be related to the ever increasing 
incidence of TC in the Nordic countries.  
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Occupational exposure 
 
Although many studies have found positive associations between occupation and risk 
of TC (Hayes et al. 1990, Marshall et al. 1990, Tarone et al. 1991, Van den Eeden et 
al. 1991, Davis and Mostofi 1993, Rhomberg et al. 1995, Knight et al. 1996, Hardell 
et al. 1998, Finkelstein 1998, Fleming et al. 1999, Andersson et al. 2003, Walschaerts 
et al. 2007), no occupation has emerged as a clear risk factor for this lesion. 
Occupational exposures to several chemical substances have also been associated with 
the risk of TC. Dimethylformamide (DMF) was implicated as a risk factor in case-
reports of TC in leather tanners (Levin et al. 1987) and aircraft repairmen (Ducatman 
et al. 1986). However, a review on DMF conducted by the International Agency for 
Research on Cancer (IARC) concluded that inadequate evidence exists to implicate 
DMF as a human carcinogen (IARC 1999). Other chemical exposures of potential 
concern include: fertilizers high in nitrogen (Kristensen et al. 1996), non-specified 
fertilizers (Haughey et al. 1989), fumes or smoke (Haughey et al. 1989) and pesticides 
(Hardell et al. 1998, Fleming et al. 1999). All these studies focused on occupational 
exposures, except for fertilizers high in nitrogen, where exposure occurred as a result 
of nutrient run-off (Kristensen et al. 1996). 
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Table 2.2. Aetiology of TC 
Risk  factor Comments 
Cryptorchidism Established risk factor: two to ten-fold increased risk of TC. 
CIS Established risk factor: 50% of patients diagnosed with CIS develop TC 
within 5 years. 
Inherited susceptibility Established risk factor: about four-fold increased risk of TC among 
father/son and more than eight-fold increased risk of TC in brothers of TC 
cases. It only occurs in 1-2.8% of all TC cases. No single gene or SNP was 
established so far. 
Ethnicity/migration Men migrating from one country to another tended to retain their country 
of origin risk of TC, whereas their children tended to approach the risk of 
the new home country. 
Prenatal and perinatal exposures 
Nausea Inconsistent findings but the effect of excessive nausea on risk of TC 
during early pregnancy may be due to rapid rise in oestrogen levels. 
Birth weight Inconsistent findings. U-shaped relation: low and high birth weight may be 
a risk factor for TC. 
Timing of delivery Inconsistent findings but preterm birth may be a risk factor of TC 
involving elevated exposure to maternal oestrogens during pregnancy. 
Parity Inconsistent findings but high parity shows decreased risk of TC compared 
to nulliparous due to higher maternal oestrogen levels in first pregnancies 
than in subsequent pregnancies. 
Twin pregnancies Up to two-fold increased risk of TC in dizygotic compared to monozygotic 
twins supports a prenatal aetiology with raised maternal oestrogen levels 
during pregnancy. 
Maternal age The effect of maternal age is unclear, probably based on the oestrogen 
excess theory. 
Retained placenta The effect of retained placenta on risk of TC is unclear. 
Maternal steroid 
hormones (high 
oestrogens and low 
androgens) 
The findings mostly come from studies using surrogates of steroid 
hormone imbalance: maternal exposure to pharmacological oestrogens, 
pregnancy characteristics, ethnicity, and reproductive abnormalities. 
Maternal EBV infection There is some support from epidemiological and histopathological studies; 
however, the real effect is unclear. 
Maternal CMV infection No studies on maternal CMV infection and risk of TC in the offspring 
have been conducted so far. 
Maternal smoking Ecological studies but no other questionnaire-based case-control studies 
have shown the association with risk of TC. 
Maternal alcohol 
consumption 
The association with risk of TC is unclear. 
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Endocrine disrupting 
chemicals 
Inconsistent findings, however, exposure to endocrine disrupting 
chemicals has recently received considerable attention as potential risk 
factors for TC. 
Postnatal exposure 
Age Peak age is between 20 to 40 years of age. 
Race Risk of TC is higher in Caucasian population compared to black or other 
non-white races. 
Androgen levels Increasing male baldness, as a surrogate for elevated androgen levels, was 
associated with 20% reduction in the risk of TC. 
Puberty Late age at puberty is associated with a 50% decreased risk of TC but not 
all studies supported this finding. 
BMI Inconsistent findings suggesting two-fold increased risk of TC with low 
BMI, three-fold increased risk of TC with high BMI or no risk of TC. 
Height Up to three-fold increased risk of TC among men taller than 185-195cm. 
Several potential mechanisms have been proposed: childhood nutrition, 
increased levels of IGF or an earlier age at puberty. 
SES Inconsistent findings but TC seems to occur much more frequently in the 
higher social classes than in the lower. 
Physical activity Inconsistent findings suggesting that higher levels of physical activity have 
a protective effect, an adverse effect or no effect. 
Diet Inconsistent findings but the risk of TC may be due to female steroid 
hormones added to dietary products (milk, meat, cheese etc). 
Urban/rural living Inconsistent findings suggesting either a rural preponderance of TC or no 
rural/urban differences in the rates of TC 
Late infection No late infection has been established as a risk factor for TC.  
Occupation No occupation has been established as a risk factor for TC. 
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3. AIMS OF THE STUDY 
 
The histological spectrum and the typical incidence peak at very young age suggest 
that risk factors for TC operate early in life, possibly already in utero. The objective 
of this study is, therefore, to assess maternal risk factors during pregnancy and the risk 
of TC in the offspring.  The aims of this study were specifically to estimate: 
 
• the effect of storage on the serum levels of three groups of hormones and 
associated proteins: steroid hormones [oestradiol, progesterone, 
testosterone, dihydroepiandrosterone sulphate (DHEAS), sex hormone-
binding globulin (SHBG)], pregnancy-specific hormones [human 
chorionic gonadotropin (hCG), placental growth hormone (pGH), alpha-
fetoprotein (AFP)], and insulin-like growth factor (IGF) family hormones 
 
• the association of maternal smoking with risk of TC in the offspring 
 
• the association of maternal EBV and CMV infections with risk of TC in 
the offspring 
 
• the association of early pregnancy maternal serum of steroid hormones: 
oestrogens (oestradiol, oestrone) and androgens (testosterone, 
androstenedione, DHEAS) and SHBG with risk of TC in the offspring. 
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4. MATERIALS AND METHODS 
 
4.1. Serum banks 
 
There are three long-standing Maternity cohort serum banks in the Nordic countries: 
the Finnish Maternity Cohort (FMC) (Oulu, Finland), the Northern Sweden Maternity 
Cohort (Umeå, Sweden), and the Rubella Screening Serum Bank (Reykjavik, Iceland) 
(Figure 2.1, p. 15; Table 4.1). In general, these biobanks offer a unique opportunity to 
study the effect of in utero exposures to the health of the offspring. 
  
The Finnish Maternity Cohort of the National Institute for Health and Welfare 
possesses serum samples from almost all pregnant Finnish women (~98%). Following 
informed consent for screening of congenital infections the samples were collected 
from women during the first trimester of pregnancy (weeks 8 to 13). Since 1983 the 
left-over sera have been stored at -25°C. 
 
The Northern Sweden Maternity Cohort is based at the University Hospital in Umeå, 
including residents of the four northernmost counties of Sweden. Blood samples are 
drawn from more than 95% of pregnant women in these counties during the first trimester 
or the early weeks of the second trimester (weeks 7 to 18) as a part of screening for 
infectious diseases. Since 1975 the serum samples have been stored at -20°C. 
 
The Rubella Screening Serum Bank at the Department of Virology, University of 
Iceland, contains serum samples collected from more than 95% of pregnant women in 
Iceland during the first trimester of pregnancy (8 to 13 weeks). Since 1975 the serum 
samples have been stored at -20°C (Pukkala et al. 2007). 
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Table 4.1. Main characteristics of the Nordic maternity cohorts 
Characteristics Finnish  
Maternity Cohort 
Northern Sweden 
Maternity Cohort 
Rubella Screening 
Serum Bank 
Location Finnish National 
Institute for Health and 
Welfare, Oulu 
University Hospital, 
Umeå 
Department of Virology, 
University of Iceland, 
Reykjavik 
First serum donation 1983 1975 1975 
Number of samples 1.71 million from 
~98%) pregnant 
women 
~121,400 from >95% 
pregnant women 
(residents of the 4 
northernmost 
counties) 
120,000 from >95% 
pregnant women 
Biological material serum samples (1st 
trimester of pregnancy: 
8–13 weeks of 
gestation)  
serum samples (1st or 
the early 2nd trimester 
of pregnancy: 7–18 
weeks of gestation)  
serum samples (1st 
trimester of pregnancy: 
8–13 weeks of gestation)  
Storage temperature 25 C 20 C 20 C 
Aim of collection screening for 
congenital infections 
screening for 
congenital infections 
screening for congenital 
infections 
Aim of storage epidemiological 
research 
epidemiological 
research 
epidemiological  
research 
 
4.2. Cancer registries 
 
The Finnish and Icelandic cancer registries are nationwide, while the regional cancer 
registry at the Oncological Center in Umeå covers the four northernmost counties in 
Sweden. Cancer registries receive notifications from hospitals, pathology laboratories 
and physicians, achieving almost 100% reporting coverage. 
 
Multiple generation linkage of the population census registries, cancer registries and 
the maternity cohort data enabled identification of women with offspring who had 
been diagnosed with TC. Approval to collate information between the FMC, the 
Population Registry and the Cancer Registry was obtained from the Ministry of Social 
Affairs and Health and the Population Census Registry of Finland (#1422/54/94). 
Relevant permissions were obtained from the Icelandic National Bioethics Committee 
(#03-013) and the Icelandic Data Protection Authority (#2003/308). Similar approvals 
were also available in Sweden from research ethics committees. 
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4. 3. Study population 
 
Study I 
 
Fourteen random samples were collected every other year from 1984 to 2004 from the 
FMC storage. Altogether 154 women during the first trimester of their first pregnancy 
were selected for the hormone analyses. Both mean and median age of the women at 
sample withdrawal was 29 years (range 25 to 34 years), (Table 4.2). 
 
The following variables have been studied: 
 
• Storage time was defined as the time between sample freezing for storage and 
sample withdrawal from the storage for the hormone analyses. The mean 
storage time for the study population was 12 years (range 2 to 22 years). 
 
• Bench-lag time (BLT) was defined as the time between sample collection and 
freezing for storage. The mean BLT for the study population was 3.5 ± 2.2 
days (range 1 to 14 days). Forty-one percent of the samples had a BLT of one 
to two days, 35% a BLT of three to four days and 24% a BLT greater than 
four days. 
 
• Gestational day (GD) was defined as the time between the first day of the last 
menstruation and sample withdrawal of the subjects, and calculated using the 
formula: 280 – (date of expected delivery – date of blood sampling at 
Maternity Care Units). The mean GD for the study population was 77.7 ± 26.7 
days (range 42 to 222 days). 
 
Studies II, III, IV 
 
The study was conducted as a pair-matched, case-control study nested within Finnish, 
Swedish and Icelandic maternity cohorts. TC cases diagnosed between 1985 and 
2003, between 1976 and 2006, and between 1979 and 2006 were identified 
respectively from the Finnish, Swedish and Icelandic cancer registries. Initially 68 TC 
cases in Finland, 34 TC cases in Northern Sweden and 13 TC cases in Iceland were 
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diagnosed with a histologically verified testicular germ cell tumour. Altogether 42 TC 
cases, 45 TC cases and 49 TC cases were excluded from the Study IV, Study III and 
Study II, respectively. The main reasons for the exclusion of 42 TC cases were 
absence of maternal serum sample in one of the maternity cohorts (36 cases) or the 
pregnancy began before the maternity cohort was established (2 cases). Among 
excluded cases one case had seminoma, three cases had teratoma, five cases had 
embryonal carcinoma, one case had yolk sac tumour, two cases had mixed germ cell 
tumour, and 26 cases (from Sweden) had no available information on histology. In 
addition, four TC cases had somatic malignancy of the testis (i.e. embryonal 
rhabdomyosarcoma). Seven TC cases (17%) were diagnosed at under 10 years of age 
(infantile/prepubertal cases), and 35 TC cases (83%) were diagnosed between 15 and 
26 years of age (postpubertal cases). Additionally, three TC cases and seven TC cases 
were excluded from Study III and Study II respectively due to these being no 
remaining maternal serum samples stored at the FMC (Table 4.2).  
 
Thus, altogether 73 TC cases, 70 TC cases and 66 TC cases whose index mothers had 
donated serum sample to one of the maternity cohorts were selected for Study IV, 
Study III and Study II respectively. Approximately nine (Study III) or four control 
mothers (Study II, IV) in Finland, four control mothers in Sweden and three control 
mothers in Iceland with male offspring free of TC at the time of diagnosis of the case 
were matched with the index mothers. The matching criterion was date of birth of the 
son (± one month). The control group comprised 286 (Study IV), 519 (Study III) and 
258 (Study II) control mothers. Descriptive statistics for maternal and offspring’s 
variables are presented in Table 4.2.  
Table 4.2. Study population 
Study Country Time of diagnosis Initial 
number 
of cases 
Final 
number 
of cases 
Number 
of  
matched 
controls 
Total Median 
maternal age 
(range), years 
Median/mean age 
at diagnosis 
(range), years 
Number of 
prepubertal TC 
cases (%) 
Number of 
postpubertal TC 
cases (%) 
Histology – number of cases 
(%) 
I Finland 1984–2004 – – – 154 29 (25–34) – – –  
II Finland 1985–2003 68 52 208      
 Sweden 1976–2006 34 8 32      
 Iceland 1979–2006 13 6 18      
 Total  115 66 258 324 28 (17–45) 17/11 (0–26) 29 (44) 37 (56) 
seminoma – 11 (16.7); 
teratoma – 21 (31.8);  
embryonal carcinoma –  
15 (22.7);  
yolk sac tumours – 14 (21.2); 
mixed germ cell tumour – 4 
(6.1); 
choriocarcinoma – 1 (1.5%)  
 
III Finland 1985–2003 68 56 469      
 Sweden 1976–2006 34 8 32      
 Iceland 1979–2006 13 6 18      
 Total  115 70 519 589 28 (17–47) 15/10 (0–25) 31 (44) 39 (56) 
seminoma – 11 (16.7); 
teratoma – 24 (31.8);  
embryonal carcinoma –  
16 (22.7);  
yolk sac tumours – 14 (21.2); 
mixed germ cell tumour – 4 
(6.1); 
choriocarcinoma – 1 (1.5%)  
 
IV Finland 1985–2003 68 59 236      
 Sweden 1976–2006 34 8 32      
 Iceland 1979–2006 13 6 18      
 Total  115 73 286 359 28 (17–45) 17/11 (0–25) 31 (44)* 39 (56)* 
seminoma – 11 (16.7); 
teratoma – 24 (31.8);  
embryonal carcinoma –  
16 (22.7);  
yolk sac tumours – 14 (21.2); 
mixed germ cell tumour – 4 
(6.1); 
choriocarcinoma – 1 (1.5%)* 
 
* Three TC cases had unknown histology and age at diagnosis 
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4. 4. Laboratory methods 
 
All study samples were blinded before they were sent to the analysing laboratory in 
order to ensure protection of integrity and similar processing of cases and controls. 
Each case and control had a code indicating its case-control status but did not include 
personal information that could connect the samples to the donors. Assays were 
performed in batches of 76 serum samples, analysed together on the same day and 
with the same laboratory kit. Serum samples of case and control subjects that were 
matched together were systematically analysed within the same batch.  
 
Study I 
 
A total volume of 370 L from 154 previously unthawed serum samples was 
aliquoted from each sample and sent to the Department of Medical Bioscience, 
University of Umeå, Sweden for the hormone and protein measurements. 
Quantification of serum hormones and associated binding-proteins was performed in 
the same series of analyses using commercial competitive or non-competitive 
enzyme-linked or radio- immunoassays. Specifications of the hormone assays and 
intra- and inter-assay coefficients of variation (CV) obtained from the manufacturers 
are given in Table 4.3. 
 
Table 4.3.  Assay methods used 
Range of coefficient of 
variation (%) 
Analyte Method 
Intra assay Inter assay 
Oestradiol ALPCO Diagnostics Oestradiol EIA 7.5-12.2 8.2-12.1 
Progesterone R&D Systems’ Progesterone EIA 4.9-7.6 2.7-8.3 
Testosterone DPC IMMULITE 2000 Total testosterone 
Chemiluminescent EIA 
5.1-16.3 7.2-24.3 
DHEAS DPC IMMULITE 2000 DHEA-SO4 Chemiluminescent EIA 4.9-9.8 7.9-13 
SHBG DPC IMMULITE 2000 SHBG Chemiluminescent EIA 0.03-4.2 4.0-6.6 
hCG DPC hCG Coat-A-Count IRMA 2.6-5.8 4.6-7.0 
AFP DPC IMMULITE 2000 AFP Chemiluminescent EIA 2.1-6.3 4.5-12 
pGH BIOCODE-HYCEL pGH IRMA 3.0-5.5 5.0-7.9 
IGF-1 DSL IGF-1 ELISA (DSL-10-2800) 4.5-8.6 3. 3-6.8 
IGFBP-3 DSL IGFBP-3 ELISA (DSL-10-6600) 7.3-9.6 8.2-11.4 
total IGFBP-1 DSL Total IGFBP-1 ELISA (DSL-10-7800) 1.7-4.6 6.2-7.6 
np IGFBP-1 Medix Biochemica IGFBP-1 IEMA  4.4-5.4 4.4-5.9 
 
Note: EIA – enzyme immunoassay; IRMA - immunoradiometric assay; ELISA - enzyme-linked 
immunosorbent assay; IEMA - immunoenzymetric assay. 
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Study II 
 
Immunoglobulin (Ig)M and IgG antibodies to EBV and CMV were determined 
according to manufacturers’ instructions by means of commercial standard enzyme-
linked immunosorbent assays (ELISAs). These measurements were performed at the 
National Institute for Health and Welfare, Oulu, Finland. For EBV IgM and IgG 
antibodies to viral capsid antigen (VCA), a commercially available ELISA (Panbio 
Diagnostics, Brisbane, Australia) was used with reported >85.7% and 100% 
sensitivity, >87.5% and >87.2% specificity respectively. For CMV IgM and IgG, 
ELISA (Biokit, Barcelona, Spain) was used with reported 93.8% and 97.6% 
sensitivity and 97.8% and 99.5% specificity respectively. The cutoff levels were 
preassigned by following the manufacturers’ recommendations relative to internal 
positive and negative reference sera used on all plates. Median IgG antibody level was 
used as an alternative cutoff for high IgG antibody levels. Specificity of the response 
was controlled for by separately considering IgM positives that were positive for only 
one of the two IgM tests. 
 
Study III 
 
The laboratory analysis was performed at the National Institute for Health and 
Welfare, Kuopio, Finland. Serum cotinine levels were measured by novel HPLC-
MS/MS system. HPCL-MS/MS system used was Waters 2695 Separations System 
(Milford, MA, USA) connected to Finnigan TSQ Quantum Discovery Max triple 
quadrupole mass spectrometer (San Jose, CA, USA) operated in the atmospheric 
pressure chemical ionization-mode. In the HPLC system Waters XTerra C18 column 
was used (50 mm length, 2.1 mm diameter, 3.5 m particles size). Limit of 
quantitation (LOQ) was 2.0 ng/ml calculated as six times standard deviation of blank. 
The linear range of the method was from LOQ to 1000 ng/ml and expanded 
measurement uncertainty was estimated to be 35%. 
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Study IV 
 
Measurements of serum levels of steroid hormones and associated binding protein 
were performed at the Department of Medical Biosciences, University of Umeå, 
Umeå, Sweden. Serum DHEAS and androstenedione levels were measured by 
competitive chemiluminescent enzyme- immunoassay (DPC Immulite 2000 DHEA-
SO4 Chemiluminescent EIA, UK; DPC Immulite 2000 Androstenedione 
Chemiluminescent EIA, UK respectively). Serum total testosterone, total oestradiol 
and oestrone levels were measured by competitive radioimmunoassay (DPC Coat-A-
Count Total Testosterone RIA, USA; Spectria Oestradiol Sensitive RIA, Orion 
Diagnostica, Finland; DSL Oestrone RIA, DSL-8700, USA, respectively). Serum 
SHBG level was measured by chemiluminescent immunometric assay (DPC Immulite 
2000 SHBG, UK).  
 
The inter-assay CV calculated for the laboratory determined commercially available 
control sera included in each assay run were 4.1% for DHEAS at 5.1 mol/L, 5.8% 
for androstenedione at 4.3 ng/mL, 5.5% for testosterone at 3.9 nmol/L, 13.4% for 
oestradiol at 530 pmol/L, 12.2% for oestrone at 310 pg/mL and 6.2% for SHBG at 74 
nmol/L. Serum free testosterone and free oestradiol levels, unbound to SHBG or 
albumin, were calculated from the absolute levels of each of the steroids and SHBG 
using mass action equations, and assuming a constant serum albumin level of 43 g/L 
(Rinaldi et al. 2002).  
 
4.5. Statistical methods 
 
Descriptive statistics were calculated for each variable separately in each Study. The 
seroprevalence was determined for EBV and CMV. Differences in seroprevalences 
between groups were tested by chi-square test (Study II). All measured hormone and 
other protein levels were ln-transformed to reduce departures from the normal 
distribution (Study I, IV). Box-plots were drawn for the hormone levels and storage 
time (Study I). Spearman’s partial ranked correlation coefficient (rs) was used to test 
for correlation between the serum hormone levels and 1) maternal smoking, 2) 
maternal age (Study IV), 3) storage time, 4) BLT, 5) GD at serum sampling (Study I). 
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The effect of BLT on hormone levels was evaluated on a continuous scale by 
multivariate regression analysis. Additionally, a nonparametric local regression model 
with smoothing parameters set from 0.1 to 1 was fitted to describe the effect of GD on 
variation of hormone levels. The best smoothing parameter was chosen for every 
hormone according to the smallest AICc1 statistics for all the smoothing parameters 
that were specified in the model statement. These analyses were done using (GLM), 
(CORR) and (LOESS) procedures of the SAS program version 9.1 (Study I). 
 
Relative risks, expressed as OR and their 95% confidence intervals (CI) were 
estimated by conditional logistic regression (Studies II, III, IV). Quartile cut points for 
hormone levels were used to estimate the relative risks. Linear-by-linear association 
test was used to present p-value for trend in OR for hormone levels divided by 
quartile cut points. Multivariable models were adjusted for GD, maternal age and 
maternal smoking status (Study IV). 
 
Separate analyses were performed for the two main histological sub-groups of TC, 
seminomas and nonseminomas; for two groups according to age at diagnosis (8 
years of age and 15 years of age) (Studies II, III, IV); for the two groups of maternal 
age (17–28, 29–47 years of age); and for the four groups of cotinine level: non-
smokers (<5 ng/ml), passive smokers (5–14.9 ng/ml), light smokers (15–99.9 ng/ml) 
and heavy smokers (100 ng/ml), (Study III). Homogeneity of ORs across age at 
primary diagnosis and histological sub-groups was tested according to Breslow and 
Day (Breslow and Day 1980; Study II). Two-sided p<0.05 was considered statistically 
significant. The relative risk analyses were performed using SPSS for Windows 15.1 
(SPSS, Inc., Chicago, Illinois). 
 
In the meta-analysis Mantel–Haenszel fixed-effects model was used to calculate the 
summary estimate. Two-sided p<0.05 was considered statistically significant. Chi-
square test for heterogeneity was evaluated (p<0.1 was considered representative of 
significant statistical heterogeneity) Statistical analysis for meta-analysis was 
performed with R version 2.5–1 (R Development Core Team, Study III).
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5. RESULTS 
 
Study I 
Stored FMC serum samples can be used to study hormone-disease associations 
 
A decrease by storage time was shown for serum levels of progesterone (rs=0.36), 
IGF-I (rs=0.23) and IGFBP-3 (rs=0.38), whereas an increase by storage time was 
found for oestradiol (rs=0.23), SHBG (rs=0.16), and AFP (rs=0.20) levels, and serum 
levels of non-phosphorylated (np) IGF binding protein (BP)-1 (rs=0.27). No 
correlation was observed between the storage time and serum levels of testosterone, 
DHEAS, hCG, pGH and total IGFBP-1. 
 
There was no correlation between BLT and any of the hormones analysed. 
  
Samples from individuals with GD between 40 and 120 days (145 women) were used 
for the analysis of the impact of GD. Hormone levels by GD followed the dynamics 
of the pregnancy. Serum levels of oestradiol (rs=0.42), progesterone (rs=0.21), SHBG 
(rs=0.54), pGH (rs=0.66), AFP (rs=0.7), total IGFBP-1 (rs=0.54), np IGFBP-1 
(rs=0.49) increased with increasing GD, while levels of DHEAS (rs=0.25) and hCG 
(rs=0.37) levels decreased with increasing GD. 
 
Study II 
Increased risk of TC in the offspring of mothers with high antibody levels to EBV – 
but no consistent association with antibodies to CMV 
 
Almost all index and control mothers were positive for IgG EBV. Therefore, median 
IgG antibody level was used as a cutoff for low and high IgG antibody levels. A 
tentative association was identified in the high EBV IgG antibody group (OR, 2.50; 
95% CI, 1.15–5.40) compared to low EBV IgG antibody group. The association was 
especially true for high EBV IgG antibody level and nonseminoma TC (OR, 2.73; 
95% CI, 1.25–5.99). Further division of the nonseminoma cases by age at diagnosis 
yielded a statistically significant high EBV IgG antibody associated risk of TC 
occurring in the infantile/prepubertal period (OR, 2.72; 95% CI, 1.05–7.04) (Table 
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5.1).  
 
By contrast, the risk of TC in cases diagnosed in the infantile/prepubertal period 
tended to be decreased among the offspring of CMV seropositive women (OR, 0.35; 
95% CI, 0.14–0.89) (Table 5.1). 
 
Table 5.1. Odds ratio (95% CI) of TC associated with maternal EBV and CMV antibodies, 
stratified by histological type and age at diagnosis. 
Epstein-Barr virus Cytomegalovirus 
IgM IgG† IgM IgG 
Category Number
(cases/ 
controls) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
Age at diagnosis, years‡      
Infantile/prepubertal period, ( 8) 29/115 n.a. 2.72 (1.05–7.04) n.a. 0.35 (0.14–0.89) 
Postpubertal period, (15; 26) 37/143 n.a. 2.96 (0.88–9.39) 1.0 (0.11–8.94) 2.97 (0.87–10.17) 
      
Histology       
Non-seminoma 55/214 n.a. 2.73 (1.25–5.99) 0.66 (0.08–5.53) 0.80 (0.39–1.64) 
Infantile/prepubertal period, ( 8) 29/115 n.a. 2.72 (1.05–7.04) n.a. 0.35 (0.14–0.89) 
Postpubertal period, (15; 26) 26/99 n.a. 2.75 (0.69–11.01) 1.33 (0.14–12.81) 3.08 (0.68–13.94) 
      
Seminoma  11/44 n.a. 3.68 (0.31–43.26) n.a. 2.75 (0.33–23.05) 
Postpubertal period, (15; 26) 11/44 n.a. 3.68 (0.31–43.26) n.a. 2.75 (0.33–23.05) 
 
Note: There were no TC cases between 8 and 15 years of age. 
† Subjects with low and high IgG antibody levels to EBV included in the model. 
‡ Included cases with all histological types. 
 
Study III 
No excess risk of TC in the offspring of mothers smoking during pregnancy 
 
No statistically significant association between maternal serum cotinine level and risk 
of TC in the offspring was found (OR, 0.68; 95% CI, 0.35–1.34). The value of 15 
ng/ml was used as a cutoff level for smokers and non-smokers. The point estimate 
was also similar for infantile/prepubertal and postpubertal TCs. There was no 
statistically significant difference between the seminoma and nonseminoma cases.  
 
A literature search for the meta-analysis was carry out in PubMed up to January 2008 
using search terms “maternal”, “smoking”, “epidemiology”, “offspring”, (“testicular” 
or “testis”), (“cancer” or “tumour” or “malignancy”) and with no language 
restrictions. Additionally, references from relevant publications and review articles 
were checked. Out of a total of 17 publications, seven were eligible for further 
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analysis fulfilling the selection criteria of sufficient information on exposure (obtained 
via questionnaires/interviews with answer “Yes/No” or number of cigarettes smoked 
per day), outcome (obtained via hospital or population based registries) and study 
design (case-control or nested case-control studies). To be included in meta-analysis, 
studies had to present number of cases and controls and information on measures of 
relative risk (unadjusted and/or adjusted ORs). Data concerning study design, 
population characteristics, matching factors for cases and controls, adjusted factors for 
the multivariate analysis were extracted from these studies using a standardized data 
abstraction form (Table 5.2). Meta-analysis included a total of 2,149 TC cases. The 
summary estimate of meta-analysis supported our results and indicated no association 
between maternal smoking and risk of TC in the offspring (OR, 1.0; 95% CI, 0.88–
1.12, Table 5.2). 
 
Table 5.2. Selected characteristics of studies on the association between maternal smoking and TC in the offspring. 
Author, year 
 
Study 
design 
Source of cases/ 
controls 
Source of smoking 
data 
Case 
recruitment 
period 
Matching factors Adjusting factors Cases 
(No)† 
Controls 
(No)† 
OR (95% CI) 
Swerdlow, 1987 CCS Radiotherapy 
centres/hospital 
controls 
Interview, case notes 1977–1981 Age (the same)  218 404 1.01 (0.71–1.45) 
Moller, 1996 CCS Cancer 
Registry/Central 
Person Register 
Interview, 
questionnaire 
1986–1988 Year of birth  296 287 0.97 (0.69–1.36) 
Weir, 2000 CCS Cancer 
Registry/Ministry of 
Revenue’s 
Enumeration 
Composite Records 
Interview, self-
administered 
questionnaire 
1987–1989, 16-
59 yrs of age 
Age (the same within 
5-yrs age groups) 
Age, exogenous 
hormone use during 
pregnancy, 
bleeding/threatened 
miscarriage, 
pregnancy length, 
treatment for 
undescended testicle 
339 511 0.86 (0.64–1.17) 
Coupland, 2004 CCS Cancer treatment 
centres or regional 
cancer 
registries/hospital 
controls 
Interview, 
Questionnaire 
1984–1987, 15-
49 yrs of age 
Date of birth (within 
1 yr) 
Age, place of 
residence 
446 420 1.22 (0.91–1.63) 
McGlynn, 2006 CCS Military medical 
databases/Defence 
Serum Repository  
Interview, 
questionnaire 
 
2002–2005, 0-
46 yrs of age 
Age (within 1 yr), 
race, date of serum 
sample drawn (within 
30 days) 
Son’s age, race, 
family history of TC 
514 560 1.01 (0.80–1.29) 
Pettersson, 2007a NCCS§ Cancer 
Registry/hospital 
controls 
Birth registry 
(records in 
standardised manner) 
1973–2002, 
15 yrs of age 
Date of birth (first 
three control children 
born after case child) 
Age, histology, 
maternal age, birth 
order, gestational 
duration. 
192 494 0.90 (0.64–1.26) 
Sonke, 2007 CCS* Registry, hospital 
based/case nominated 
Interview, self-
administered 
questionnaire 
1990–1996, 
18–50 yrs of 
age 
Race, age (±5 yrs), 
state of residence 
Mother’s race, 
education, body mass 
index, son’s birth 
weight, age, history 
of cryptorchidism, 
nausea, length of 
pregnancy 
144 86 1.1 (0.50–2.2) 
Summary estimate, Mantel-Haenszel OR: 1.0; 95% CI: (0.88, 1.12) 
 
Test for heterogeneity: Chi2 = 3.02; (p-value, 0.8) 
* Case-control study; 
§ Nested case-control study; 
† Number of cases and controls eligible for the smoking exposure data; 
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Study IV 
The interplay of maternal steroid hormones in early pregnancy is important in the 
aetiology of TC in the offspring 
 
Quartile cut points for hormone levels were used to estimate the ORs. Offspring of 
mothers with the highest DHEAS levels had a significantly decreased risk of TC 
adjusted for GD, maternal age and maternal smoking status (OR, 0.18; 95% CI, 0.06–
0.58). However, offspring of mothers with the highest androstenedione levels had an 
increased risk of TC adjusted for GD, maternal age and maternal smoking status (OR, 
4.05; 95% CI, 1.2–12.0), (Table 5.3). Comparable decreased risk of TC associated 
with increased DHEAS level (OR, 0.36; 95% CI, 0.17–0.74), and increased risk of TC 
associated with increased androstenedione level (OR, 3.1; 95% CI, 1.05–9.2) were 
also observed using log-transformed continuous scales of the hormone levels. With 
adjustment removed the ORs were the same as when adjusted. The results were 
similar when the Finnish data was analysed separately. 
 
In a stratified analysis using the continuous scale, the risk of TC in cases diagnosed 
under 8 years of age (the infantile/prepubertal period) and risk of nonseminoma TC 
adjusted for GD, maternal age and maternal smoking status tended to be decreased 
among the offspring of women with increased DHEAS level (OR, 0.10; 95% CI, 
0.01–0.80), (OR, 0.11; 95% CI, 0.03–0.51) respectively. The opposite was true for 
increased androstenedione level (OR, 47; 95% CI, 2.3–970), (OR, 27; 95% CI, 2.7–
270) respectively. Other maternal steroid hormone levels and risk of TC in the 
offspring did not show statistically significant differences in the different histology 
and age groups (data not shown). 
 
High maternal total oestradiol level showed a very high point estimate for the 
increased risk of TC in the offspring adjusted for GD, maternal age and maternal 
smoking status (OR, 32; 95% CI, 0.98–1090) (Table 5.3).  
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Table 5.3. Odds ratio (95% CI) of TC associated with maternal hormone levels. 
Quartile categories Hormone 
1 2 3 4 
p for trend 
DHEAS 
Cut points, mol/L  2.5 2.6–3.6 3.7–4.9 >4.9  
Number (cases/controls) 91 (23/68) 92 (19/73) 88 (16/72) 90 (15/75)  
OR (95% CI)* 1.0 (Referent) 0.33 (0.13–0.83) 0.25 (0.09–0.71) 0.18 (0.06–0.58) 0.13 
Androstenedione 
Cut points, ng/mL 2.9 3.0–3.6 3.7–4.5 >4.5  
Number (cases/controls) 91 (12/79) 90 (21/69) 90 (20/70) 90 (20/70)  
OR (95% CI)* 1.0 (Referent) 3.6 (1.3–9.8) 3.03 (1.02–8.9) 4.05 (1.2–12.0) 0.17 
Total testosterone 
Cut points, nmol/L 1.8 1.9–2.5 2.6–3.6 >3.6  
Number (cases/controls) 93 (15/78) 90 (21/69) 89 (21/68) 88 (15/73)  
OR (95% CI)* 1.0 (Referent) 2.9 (0.9–9.1) 4.2 (1.04–16.0) 2.02 (0.36–11.0) 0.85 
Free testosterone 
Cut points, pmol/L 11.3 11.3–18.02 18.03–28.42 >28.42  
Number (cases/controls) 90 (21/69) 90 (17/73) 90 (17/73) 89 (17/72) 0.50 
OR (95% CI)* 1.0 (Referent) 0.64 (0.21–2.02) 0.39 (0.08–1.8) 0.49 (0.07–3.3)  
Total oestradiol 
Cut points, pmol/L 603 604–984 985–1880 >1880  
Number (cases/controls) 88 (10/78) 87 (23/64) 88 (19/69) 87 (18/69)  
OR (95% CI)* 1.0 (Referent) 4.7 (0.81–27) 13.0 (1.1–180) 32.0 (0.98–1090) 0.22 
Free oestradiol 
Cut points, pmol/L 7.76 7.77–11.14 11.15–18.08 >18.08  
Number (cases/controls) 87 (15/72) 88 (19/69) 87 (19/68) 87 (17/70)  
OR (95% CI)* 1.0 (Referent) 0.64 (0.17–2.3) 0.39 (0.07–1.9) 0.31 (0.03–3.3) 0.71 
Oestrone 
Cut points, pg/mL 547 547.01–864 864.01–1700 >1700  
Number (cases/controls) 91 (13/78) 91 (24/67) 90 (18/72) 89 (18/71)  
OR (95% CI)* 1.0 (Referent) 1.1 (0.24–5.1) 0.69 (0.09–5.02) 0.22 (0.01–3.8)  0.54 
SHBG 
Cut points, nmol/L 139 139.1–222.0 222.1–281 >281  
Number (cases/controls) 92 (16/76) 91 (21/70) 87 (14/73)  90 (22/68)  
OR (95% CI)* 1.0 (Referent) 0.77 (0.23–2.5) 0.28 (0.06–1.4) 0.25 (0.04–1.6) 0.47 
 
* OR (95% CI) from conditional logistic regression adjusted for gestational day (GD), maternal age and 
maternal smoking status.
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6. DISCUSSION 
 
The present studies were conducted to investigate the impact of congenital infections 
or susceptibility to perinatal infections, maternal smoking, and early pregnancy 
steroid hormones on risk of TC in the offspring. Over-generation linkage of 
population-based maternity cohorts and cancer registries enabled a unique nested 
case-control setting for the study. The risk exposures were associated from blinded, 
first trimester serum samples of the index and control mothers by state-of-the-art 
laboratory methods. Furthermore, exposure assessment from the stored sera had been 
validated. 
 
No consistent pattern of variation of the hormones or binding-proteins with storage 
time was found. Serum samples can, therefore, be used to study hormone-disease 
associations, but matching for storage time is necessary for all biobank-based studies. 
High levels of maternal EBV IgG antibodies were associated with the risk of TC in 
the offspring, especially with the risk of nonseminomatous TC diagnosed under eight 
years of age. A statistically significant association was also noted between decreased 
risk of TC diagnosed under eight years of age and maternal CMV IgG antibodies. 
Maternal serum cotinine analysis did not provide support for the hypothesis that 
maternal smoking during pregnancy is a risk factor for TC. As for the steroid 
hormones, offspring of mothers with high DHEAS levels had a significantly 
decreased risk of TC, whereas offspring of mothers with high androstenedione level 
had an increased risk of TC. Below the validity of our approach and observations, and 
the generated new data are discussed. 
 
6.1. Strengths and limitations of the study 
 
6.1.1. Biobank-based approach in the context of TC aetiology 
 
The large Nordic maternity screening cohort based biobanks used in the present 
studies offered a unique opportunity to study the impact of early pregnancy exposures 
on risk of TC in the male offspring. The examination of prospectively collected 
samples is crucial to establish the temporal relationship required for inferences on 
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causality. Epidemiological studies investigating the biological effect of pregnancy and 
maternal risk factors associated with the offspring’s cancer risk have, however, rarely 
relied on early pregnancy hormone measurements (van de Beek et al. 2004, Troisi et 
al. 2003b). Indeed, during the first trimester of pregnancy the foetus is particularly 
vulnerable to infections or metabolically active substances with a potential to 
deteriorate cellular growth and differentiation. This period of pregnancy is also 
critical for urogenital differentiation. The first trimester of pregnancy differs 
endocrinologically from the second and third trimesters. At best moderate degrees of 
correlation in steroid hormone levels between either maternal serum from the 
second/third trimester of pregnancy and amniotic fluid (van de Beek et al. 2004), or 
umbilical cord samples have not encouraged the use of maternal samples for biobank 
studies (Troisi et al. 2003b). 
 
In biobank-based studies the process from the decision to take a sample from an 
individual to the moment the sample is safely placed in the biobank consists of several 
phases including collection of samples, handling and storage of samples. Failure in 
one of these standardized procedures may have significant consequences as the 
quality of the material stored in the biobank as well as conclusions and 
recommendations based on the analysis of such material may be severely affected. 
 
Overall, the stability of steroid and other pregnancy-related hormones and associated 
binding-proteins or causes of their degradation in stored serum/plasma samples are 
not well known. The effect of storage time on the measurement of specific hormones 
may vary according to the assay method. Different antibodies may bind to different 
parts of peptide hormones, and this could affect the performance in old samples if, for 
example, the terminal amino acids are lost. There is also the potential of hormone 
measurement variability by BLT (Hankinson et al. 1989, Key et al. 1996, Masse et al. 
2000, Kristal et al. 2005).  
 
Our validation study investigated the impact of long-term storage of serum samples 
obtained from pregnant women, on the measurement of steroid and other pregnancy 
related hormones and associated proteins. The study did not show consistent 
variations in steroid hormone levels by storage time from 2 to 22 years. Some 
hormone and the associated binding-protein levels decreased and some increased with 
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increasing storage time. However, the changes did not exceed the inter-assay 
variations of the enzyme-immunological tests, and the levels of variation remained 
within the clinically normal ranges. Furthermore, no substantial effect of the length of 
BLT on the steroid and pregnancy-specific hormone and binding-protein levels could 
be found. 
 
During pregnancy the different steroid hormone levels undergo considerable 
variations. In our validation study the variation of hormone levels by GD followed the 
dynamics of the pregnancy and was in agreement with what was expected according 
to available clinical data (Speroff 1994). However, trimester-specific reference 
intervals for several hormones would have been difficult to establish due to lack of 
specificity of the enzyme-immunoassays for a given steroid hormone (Soldin et al. 
2005). Thus, in nested case-control studies considering pregnancy-related hormones 
the data on GD at sample withdrawal must be taken into account in matching. 
 
Although the reliability of the cotinine measurements and measurements of antibody 
levels to EBV and CMV in serum samples stored for a long time have not been 
evaluated in this study, there is some evidence in the literature that these markers are 
relatively stable over storage time. For instance, in one study cotinine levels retained 
their discriminant value even after ten years of storage (Riboli et al. 1995). The stored 
samples (up to 25 years) were shown to be reliable for the diagnosis of congenital 
CMV using assays for specific antibodies and pathogen nucleic acids (Nørgaard-
Pedersen and Simonsen 1999). The stability of antibodies to EBV in biological 
samples with storage time was also shown in one study (Stevens et al. 2007). 
 
6.1.2. Representativeness of the study population 
 
Testicular tumours are a heterogeneous group of neoplasms traditionally separated by 
histology (seminoma and nonseminoma) and age at diagnosis (infantile/prepubertal 
TC, postpubertal TC and spermatocytic seminoma). Each of these tumours has its 
own epidemiological, clinical, pathologic and genetic characteristics. They all 
originate from germ cells at different stages of development. The most common TCs 
(seminomas) arise in postpubertal men and are characterized genetically by having 
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one or more copies of an isochromosome of the short arm of chromosome 12 [i(12p)] 
or other forms of 12p amplification. Tumours arising in infantile/prepubertal gonads 
are either teratomas or yolk sac tumours, tend to be diploid and are not associated 
with i(12p). Furthermore, the worldwide incidence of infantile/prepubertal TC has no 
apparent evidence on trends over time (Walsh et al. 2008) whereas the incidence of 
postpubertal TC has dramatically increased over the last 40 years (Huyghe et al. 2003, 
Huyghe et al. 2007). 
 
Due to the young age of the present subjects (aged between 0 and 25 years) the 
infantile/prepubertal TC cases dominate in our study population compared to normal 
population, where these tumours are very rare (0.12–2 per 100,000 men). Especially 
low numbers of seminomas must be noted in our study population. Therefore, our 
results, probably, cannot be extrapolated to the normal population of TC cases aged 
between 20 to 40 years. However, given time the biobank based approach will also be 
valid for aetiological studies in these cancer cases, i.e., the bulk of TC. 
 
The study populations, i.e. the Nordic maternity cohorts, stem from population-based 
screening for congenital infections (e.g., syphilis), which for decades has been a 
constant component of health care in the affluent Nordic countries. Various studies 
have shown that participation in screening is virtually complete (98% of the 
population participates) (Koskela et al. 2000). This representativeness of the maternity 
cohorts has also been shown when comparing the incidences of chronic diseases in the 
maternity cohorts to those of the female population in general, with the exception of 
some cancers, e.g. ovarian cancer, where pregnancy has a significant impact (Pukkala 
et al. 2007). This, however, is not a relevant issue for studies on the aetiology of 
cancer in the offspring. 
 
The ASR of TC in Finland, Sweden and Iceland does not vary widely (3.7 per 
100,000 men in Finland; 5.3 per 100,000 men in Sweden; 5.4 per 100,000 men in 
Iceland). The majority of the cases were from Finland, and in the different analyses 
we gave both country-specific results and pooled results (with country-matched cases 
and controls) to obtain by far the largest longitudinal, over-generation linked study 
population. 
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A possible limitation of our study was also that we did not control for some pregnancy 
related characteristics not available in the maternity cohorts (e.g., cryptorchidism, 
maternal weight, birth weight, nausea etc.), which might have confounded the disease-
exposure association. Furthermore, the confidence intervals for the point estimates in 
this study are relatively large due to the small number of cases. Also, the small 
numbers of cases does not enable statistical interaction analyses. Of particular interest 
is the interaction between pregnancy-related characteristics (maternal age, maternal 
smoking etc.) and levels of steroid hormones and their risk to TC development. 
Therefore, studies with longer follow-up time and larger sample size are needed. 
 
6.1.3. Validity of the assays and analyte measurements 
 
Primary EBV infection during pregnancy seems to be rare, occurring in 
approximately 1.5% of all pregnancies (Eskild et al. 2005). Pregnant women may, 
however, have higher incidence of EBV reactivation due to immune suppression 
during pregnancy (Purtilo and Sakamoto 1982, Nakamura et al. 1993, Obel et al. 
1996, Bruu et al. 2000). EBV may cross the placenta causing foetal infections (Avgil 
and Ornoy 2006). However, serology is an indirect and non-specific measure of 
exposure to an infectious agent. High EBV VCA IgG antibodies are present following 
infectious mononucleosis and EBV reactivation, but also in asymptomatic or past 
infections. EBV VCA IgM antibodies indicate primary infection (Okano et al. 1988) 
but in EBV reactivations, the sensitivity and specificity of the VCA IgG and IgM 
antibody tests are not good (Bruu et al. 2000). Thus, other EBV tests are needed to 
confirm the reactivation of EBV infection in the index mothers during pregnancy. 
 
Nicotine addiction is strong, and indication of smoking at any time during pregnancy 
is likely to be representative of the whole pregnancy (Kullander and Källen 1971, 
Raatikainen et al. 2007). It has, however, been noted that due to the common 
knowledge of the adverse effects of smoking on the health and development of the 
foetus pregnant women tend to deny or under-report their smoking habit (Cope et al. 
2001). This is why objective indicators of current smoking are ideal indicators of 
smoking in pregnant women. It is important to note that, our cotinine results, a 
biochemically determined metabolite of nicotine, based smoking prevalence were 
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consistent with self-reported smoking prevalence among young women in Finland 
(26%) (Raatikainen et al. 2007) and in Sweden (21%) (Högberg and Cnattingius 
2007). 
 
The sensitivity (>95%) of the novel HPLC/MS/MS method we used to analyse cotinine 
was adequate. The limit for active smoking was set between 10 and 20 ng of cotinine 
per one ml. Variation of the cotinine levels in the serum samples analysed was wide, 
from less than 2 to 538 ng/ml. The criterion set for active smoking exceeding 15 ng/ml 
was represented in 20% of our study population, while 11% exceeded 100 ng/ml, which 
was considered an indicator for heavy smoking among females. 
 
In general, the steroid hormone levels we report remained within the clinically normal 
range of early pregnancy and were consistent with our validation study and earlier 
study, evaluating serum levels of steroid hormones during the first trimester of 
pregnancy (Soldin et al. 2005). The measured hormone levels did not exceed the inter-
assay variations determined by the enzyme-immunological tests. Furthermore, the 
cross-reactivity of the assays was very low, even to similar steroid hormones. 
However, the ranges of the oestrogens may be regarded as high with some outliers 
included. Indeed, GD may have had an effect on the hormone ranges. However, in 
this study matching for GD was taken into account to avoid its effect on true 
exposure-disease association. Furthermore, an appropriate descriptive way of 
expressing the variation of skewed hormone distribution was to give the median 
hormone levels, and the hormone levels at the 25th and 75th percentiles, which 
excludes the outliers. 
 
6.2. Comparison of the study results with findings from 
other studies 
 
The histological spectrum of TC and the typical incidence peak at very young age 
suggest that its risk factors operate early in life, possibly already in utero. The first 
trimester of pregnancy is the critical period for urogenital differentiation. Exposures 
acting during foetal life can disrupt the normal development of the primordial germ 
cells and/or gonocytes, generating CIS lesions (Skakkebaek et al. 1987, Rajpert-De 
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Meyts et al. 2003). This eventually gives rise to germ cell tumours of a variety of 
histological types depending on their particular stage of “developmental arrest” 
(Rajpert-De Meyts 2006). 
 
6.2.1. Association of maternal infections and risk of TC in the 
offspring 
 
In adulthood the prevalence of EBV and CMV infections, depending on age, race and 
socioeconomic status, accounts for about 8090% and 4090% of the total population 
respectively. Interestingly, primary infections with EBV and CMV occur in 
approximately 1.5% and 0.74.1% of pregnancies respectively (Eskild et al. 2005, 
Pusztai et al. 2004). Indeed, in our study population EBV IgM and CMV IgM 
antibodies were practically missing indicating absence of primary infection with EBV 
and CMV. However, EBV and CMV can pass through the placenta even if the 
infection and immune response have occurred prior to conception and are reactivated 
during the pregnancy (Avgil and Ornoy 2006, Pass et al. 2006). This may, in 
principle, contribute to testicular carcinogenesis (Lang and Kummer 1972, Mueller et 
al. 1988). In our study population, however, we could not confirm the reactivation of 
EBV and CMV infections in the index and control mothers. 
 
EBV has been considered as a possible cause of TC due to its high transforming 
potential and its association with various human neoplasms (Shibata et al. 1991, 
Iezzoni et al. 1995, Lehtinen et al. 2003, Rezk and Weiss 2007) most notably 
Hodgkin’s lymphoma (Herbst et al. 1990, Brousset et al. 1993). Indeed, Hodgkin’s 
lymphoma shows epidemiological similarities to TC with a peak age in adolescents 
and young adults (Newell et al. 1984). It has been suggested that susceptibility to both 
TC and EBV orchitis may differ before and after the completion of testicular 
differentiation (Shimakage et al. 1996). Furthermore, women with significant EBV 
reactivation tend to have shorter pregnancies and offspring with lower birth weight 
(Eskild et al. 2005). 
 
Most normal testicular deoxyribonucleic acid (DNA) samples from adolescents or 
young adults as well as testicular tumour DNA samples contain the EBV genome, but 
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the expression of viral RNA has been detected in embryonal testicular tumours 
(Shimakage et al. 1993, Shimakage et al. 1996). EBNA 2 and latent membrane protein 
(LMP) were also found in the testicular tumours (Shimakage et al. 1996). The fact 
that expression of early EBV RNA has been reported in embryonal carcinomas but 
not in seminomas (Shimakage et al. 1993) is in line with our results. To rule out the 
possibility that EBV reactivation is a marker of a pathogenetic process rather than the 
causal factor (Akre et al. 1999, Sundström et al. 2004, Eskild et al. 2005) further 
studies are needed. 
 
Protection against childhood TC was associated with the presence of maternal CMV 
IgG antibodies. This finding may not have an interpretation. It suggests that CMV 
infection of the infant may be associated with the risk of TC. Indeed, testicle is a site 
exposed to CMV (Lang and Kummer 1972). Hence, CMV infection could from the 
early years of life induce carcinogenic alterations in the testicular tissue. Further 
studies, however, are needed to confirm the role of CMV infection in TC. 
 
6.2.2. Association of maternal smoking and risk of TC in the 
offspring 
 
An examination of parallel trends in rates of TC and female lung and bladder cancers 
led author to hypothesise that maternal smoking is the risk factor for TC 
(Clemmensen 1997). In addition, one ecological study showed a highly significant 
association between prevalence of female smoking and incidence of TC in the Nordic 
countries. This was, however, not true for Finland. Both the prevalence of smoking 
among females and TC incidence were highest in Denmark and lowest in Finland 
(Pettersson et al. 2004). On the other hand, several questionnaire-based studies with 
sufficient information on exposure, outcome and possible confounding factors have 
not shown an association between maternal smoking and risk of TC (Brown et al. 
1986, Swerdlow et al. 1987, Weir et al. 2000, Coupland et al. 2004, McGlynn et al. 
2006, Pettersson et al. 2007a, Sonke et al. 2007). The source of the data in these 
studies, however, may be a concern due to possibly lower participation rate of 
mothers who smoked in pregnancy. The present study also provides no evidence for 
an association between maternal smoking and risk of TC, when smoking status was 
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based on a biological measurement, serum cotinine levels. To the best of our 
knowledge this is the first study on TC risk in the offspring and maternal serum 
cotinine levels. 
 
An association between maternal smoking and TC may be affected by another 
potential common risk factor such as alcohol consumption. However, no association 
was found between childhood germ cell tumours and maternal alcohol intake in 
several studies (Weir et al. 2000, Chen et al. 2005a). Moreover, there are no reliable 
methods to determine alcohol consumption from the stored serum samples. 
 
Although pregnancy smoking cannot be entirely discarded as a minor risk factor for 
TC, we believe that our biobank-based study together with previous questionnaire-
based studies included in our meta-analysis provide strong evidence to rule out 
smoking as the cause of the epidemic rise in TC observed in many populations. 
 
6.2.3. Association of maternal steroid hormones and risk of TC 
in the offspring 
 
According to the leading hypothesis on TC aetiology, exposure to a specific pattern of 
steroid hormones in utero is the major determinant of TC risk. In particular, high 
oestrogen and low androgen levels are believed to be aetiologically important 
(Henderson et al. 1979, Henderson et al. 1988a, Henderson et al. 1988b, Sharpe and 
Skakkebaek 1993, Sharpe 2003). The present study is the first to evaluate the 
association of early pregnancy steroid hormone levels with the risk of TC in the 
offspring. Indeed, DHEAS is a precursor of steroid hormones and a major source for 
oestrogen formation in the foeto-placental unit. About one half of total oestradiol 
produced in the placenta originates from maternal DHEAS (Tagawa et al. 2004). 
During pregnancy, the maternal adrenal production rate of DHEAS is doubled, but the 
maternal serum level of DHEAS is reduced down to one-third of the non-pregnancy 
level (Braunstein 2002, p799). The decrease of DHEAS is associated with increasing 
oestrogen levels due to enhanced oestrogen biosynthesis by the placenta (Tagawa et 
al. 2004). As gestation advances, increasing quantities of 17-oestradiol are 
synthesized from the conversion of circulating maternal and foetal DHEAS. At term, 
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approximately equal amounts of oestrogens are produced from circulating maternal 
and foetal DHEAS (Tulchinsky and Hobel 1973). 
 
Androstenedione produced either from DHEAS or 17-hydroxyprogesterone is a 
precursor of testosterone and oestrogens. Because DHEAS and androstenedione share 
the same metabolic pathways it is natural that their serum levels correlate positively 
with one another. However, maternal serum DHEAS and androstenedione level 
associated point estimates of TC were opposite, and we do not have a good 
explanation for this. 
 
Decrease of androgen levels with increasing age at pregnancy is probably a risk factor 
for TC in the offspring. Moreover, serum DHEAS and androstenedione levels decline 
after the third decade of life, and in our study both DHEAS and androstenedione 
levels were inversely correlated with maternal age. Various studies have, however, 
found increased maternal age to be associated with an increased risk of TC (Moller 
and Skakkebaek 1997, Sabroe and Olsen 1998), a decreased risk of TC (Cook et al. 
2008b, Dusek et al. 2008) or no risk of TC (Swerdlow et al. 1982, Weir et al. 2000). 
Crude and maternal age adjusted statistical analyses of our results showed comparable 
opposite associations for DHEAS and androstenedione with the risk of TC. Although 
in our study maternal smoking status was not associated with a risk of TC, it was still 
positively correlated with DHEAS and androstenedione but not with other hormones.  
 
A better knowledge on the impact of populations’ lifestyle and environment on 
endogenous hormone metabolism during pregnancy and its role in TC development is 
needed. TC associates with cryptorchidism, hypospadias and low sperm counts, and 
may also be considered as a disorder of TDS. Causes of TC including environmental 
chemical exposure can lead to deficiency in androgen, in particular testosterone 
production/action or malfunctions of the Leydig and/or Sertoli cells during foetal 
testis development (Skakkebaek et al. 2001, Sharpe and Skakkebaek 2008). In 
addition, the oestrogens hypothesis postulates that the increasing incidence of 
reproductive abnormalities in the human male may also be related to increased 
oestrogen exposure in utero (Henderson et al. 1979, Henderson et al. 1988a, 
Henderson et al. 1988b, Sharpe and Skakkebaek 1993, Sharpe 2003). Recently the 
endocrine-disrupting chemicals hypothesis emerged, suggesting that some of the 
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increase in TC incidence in recent decades could be due to the accumulation of these 
chemicals in the environment (Hardell et al. 2006, McGlynn et al. 2008). Therefore, 
further studies are needed to confirm the role of endocrine-disrupting chemicals in 
endogenous hormone metabolism during pregnancy and risk of TC in the offspring. 
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7. CONCLUSIONS 
 
TC is the most common cancer in young men (aged between 20 and 40 years), 
however, compared to other human cancers, it is a rare disease. In populations 
considered to have high frequency of the disease, its lifetime incidence is 
approximately 0.5%. Thus, the present study on the epidemiology and aetiology of TC 
was motivated predominantly by biological and clinical interest. 
 
The findings of this study permit the following conclusions to be drawn: 
 
1. The serum samples of the FMC, preserved for up to 22 years at –25 oC can be 
used to study hormone-disease associations. However, matching for storage 
time, a common design component of nested case-control studies, is needed to 
control for the observed variations in the hormones. 
 
2. To the best of our knowledge this was the first study exploiting early 
pregnancy serum samples for the evaluation of the association of congenital 
infection with EBV and CMV and the risk of TC in the offspring. We found 
significantly more frequently elevated EBV IgG antibody levels in the mothers 
of nonseminoma TC cases than in the control mothers. This indicates that 
activation of EBV infection during pregnancy may have a role in the 
development of nonseminomatous TC, as has been suggested by a number of 
studies showing genetic material of the virus in the carcinoma cells.  
 
3. There was no association between maternal smoking as measured by cotinine 
level in serum samples from the first trimester of pregnancy and risk of TC in 
the offspring. This is in agreement with a meta-analysis of seven 
epidemiological studies using questionnaire-based data on maternal smoking. 
 
4. Determination of early pregnancy serum steroid hormone levels in the index 
and control mothers with the risk of TC generated new support for the 
intriguing role of high oestrogen and low androgen levels in risk of TC. We 
presented evidence that endogenous steroid hormones, especially DHEAS and 
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androstenedione, in early pregnancy play an important role in the aetiology of 
TC in the offspring. However, further studies with longer follow up time and 
larger sample size are needed. A better understanding of the impact of 
populations’ lifestyle and environment on endogenous hormone metabolism 
during pregnancy and its role in TC is needed. 
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